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ABSTRACT 
 
Diabetes is often associated with a number of medical complications as a result of the 
metabolic changes taking place systemically. There is considerable evidence it is 
associated with oral complications including among others, gingivitis, periodontal 
disease, xerostomia, oral candidiasis, dental caries, periapical abscesses, lichen planus, 
burning mouth syndrome and an altered taste sensation (Lamster et al. 2008;  Skamagas 
et al. 2008; Vernillo, 2003). The aim of the present study was to compare the oral health 
status in diabetic and non-diabetic patients with regards to their oral health problems, oral 
pathology and self perceived quality of life.   
 
A comparative cross-sectional study to determine the common oral complications 
prevalent in diabetics and non-diabetics was carried out in KwaZulu-Natal, at Prince 
Mshiyeni Memorial, EThekwini District, Umlazi. The study sample consisted of 150 
diabetic patients and 150 non-diabetic patients attending the hospital. The oral health 
status was assessed clinically for each patient and recorded prior to the interview. The 
DMFT, plaque index and appearance of marginal gingiva were used to assess oral health 
status. An intra-oral examination was carried out to identify oral pathology lesions and 
other oral problems. Patients were then interviewed on the self perceived quality of life 
and the impact that diabetes has had on their lives.  
 
Plaque Index and DMFT were significantly higher among the diabetic group as opposed 
to the non-diabetic group. Periodontal disease was observed in more than half of the 
diabetic group as opposed to only 14.7% of the non-diabetic group.  
 
Except for tooth decay, the diabetic patients had more oral health problems compared to 
the non-diabetic group. More than half of the diabetic group reported having xerostomia 
compared to only 7.3% of the non-diabetic group. Altered taste sensation was also more 
prevalent in the diabetic group. In general, the diabetic group demonstrated a higher 
prevalence of oral pathology lesions and medical diabetes complications compared to the 
non-diabetic group.  
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The self perceived quality of life was said to have deteriorated in 92% of diabetic subjects 
due to concomitant diabetic complications and 75% of this group indicated that they were 
not satisfied with their current quality of life. 
 
Diabetic patients were significantly less likely to perceive their quality of life as very 
satisfied after having adjusted for age and gender variables (OR=0.0188; CI: 0.0059-
0.0594). Furthermore, diabetic patients were almost 6 times more likely to perceive 
themselves as “not satisfied” with their quality of life (QOL) as compared to non-diabetic 
patients. 
 
Individuals with diabetes exhibited poorer oral health when compared to non-diabetics. 
They exhibited a higher DMFT and had a significantly higher average number of missing 
teeth compared to the non-diabetic group. Special care needs to be given to diabetic 
patients because of the associated complications to improve their quality of life. A more 
detailed and in-depth study that utilises a diabetes-specific quality of life instrument may 
provide a more accurate way of determining the quality of life as well as periodontal 
disease in patients. 
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CHAPTER ONE: INTRODUCTION 
 
Diabetes mellitus (DM) is described as one of the most common endocrine diseases in 
medicine (Clark, 2006; Bjelland et al. 2002; Zielinski et al. 2002) or the most common 
chronic disorder (Almas et al. 2003). It has reached epidemic proportions (Papadopoulos 
et al. 2007) despite the fact that not every diabetic case is reported and it is expected to 
rise as the ageing of the population will result in more people succumbing to it (Bjelland 
et al. 2002). 
 
Diabetes Mellitus encompasses a heterogeneous group of disorders with the common 
characteristic of altered glucose tolerance and impaired lipid and carbohydrate 
metabolism (Karima et al. 2005). The disease is a growing public health problem 
(Mealey, 2008; Ogunbanjo, 2006; Tan et al. 2006; Murrah, 1985) because its associated 
complications give rise to socio-economic and disease burdens that put an enormous 
strain on the health care systems in many countries (Wilder et al. 2009; Papadopoulos et 
al. 2007 and Mbokazi, 2006), including South Africa. Diabetes exerts a heavy economic 
burden on society because of health system costs incurred in managing the disease, 
indirect costs resulting from productivity losses and premature mortality (Kirigia et al. 
2009). Diabetes mellitus accounts for 5% of all deaths worldwide and it results in 
morbidity and mortality in both developing and developed countries (Skamagas et al. 
2008). In the United States alone about 20.8 million people are estimated to have diabetes 
(Kapp et al. 2007) and it continues to rise due to the increasing number of overweight and 
obese individuals (King, 2008). There is evidence to suggest that women are at a higher 
risk of mortality and morbidity from diabetes (Gucciardi et al. 2008). 
 
DM is a pernicious chronic disorder of the carbohydrate, fat and protein metabolism 
(Crawford, 1997; Vernillo, 2003) which is regarded as a true metabolic disorder as its 
effects are far-reaching, leading to pathological changes in every tissue of the body. It is 
characterized by a very distinct feature, the elevation in blood glucose levels that may 
occur as a result of a defect in insulin secretion from the pancreas, a change in insulin 
action or both (Almas et al. 2003; Mealey, 2003; Crawford, 1997).  
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The process leading to hyperglycaemia is fairly complex and it involves changes in 
chemical pathways and metabolic changes. An increase in cellular resistance to the action 
of insulin causes a series of metabolic irregularities involving carbohydrates, fats and 
proteins (Lamster et al. 2008), that result in micro- and macrovascular disease - the 
leading causes of death among diabetic patients. 
 
Diabetes reduces the life expectancy of an individual diagnosed at 40 by about 12 years 
for men and 14 years for women (Skamagas et al. 2008). This is a cause for concern as a 
substantial increase in the number of diabetic people is anticipated worldwide. By the 
year 2025, the prevalence of diabetes is estimated at more than 300 million (Taylor and 
Borgnakke, 2008; Campus et al. 2005), a clear indication that this public health problem 
is on the increase. 
 
It is critical therefore that oral health workers have a clear understanding of the disease in 
terms of its diagnosis, prevention and treatment so as to improve the quality of care 
offered to such patients (Rees, 2000). 
 
Dentists can play a pivotal in identifying a diabetic patient, especially since diabetes is 
associated with oral complications. They can influence the diagnosis, treatment, 
management and prognosis of such patients by diagnosing their diabetes-associated oral 
complications and promptly referring the patient to a physician. There is no cure for 
diabetes and the dentist can play a role in glycaemic control of this disease by 
maintaining good oral hygiene on their diabetic patients and by motivating them to 
maintain good glycaemic control as this will prevent or slow down the progression of 
associated medical and oral diabetic complications. An elevation in blood glucose levels 
(hyperglycemia) affects almost all body tissues including the oral cavity although most 
literature focuses on the medical effects of diabetes rather than on oral health effects. The 
aim of the present study was to determine the prevalence of oral lesions amongst diabetic 
and non-diabetic patients, including periodontal deterioration; the self perceived quality 
of life and the prevalence of medical and oral complications closely related to diabetes.  
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CHAPTER TWO: LITERATURE REVIEW 
 
This chapter provides an overview of diabetes in terms of its classification, epidemiology, 
associated risk factors, pathogenesis, diagnosis and management. The oral complications 
of diabetes are discussed as well as the role that dentists may play in management of the 
diabetic patient with special reference to diabetic emergencies. 
Diabetes is a heterogenous group of disorders caused by a relative or absolute insulin 
deficiency which causes abnormalities of carbohydrate, protein and lipid metabolism 
(Ogunbanjo, 2006). It is pernicious in character and has strong associations with 
numerous co-morbid conditions. Its primary feature is hyperglycaemia that results from 
decreased insulin production, insulin dysfunction or lack of insulin receptor 
responsiveness at target organs (Almas et al. 2003; Mealey, 2003; Bjelland et al. 2002). 
 
2.1.  Classification of diabetes 
 
The classification of Diabetes Mellitus is based on pathogenic processes that can lead to 
absolute or relative insulin deficiency, leading to hyperglycaemia, a cardinal feature of 
diabetes (Kidambi and Patel, 2008). It can be classified into three broad categories 
according to its signs and symptoms, namely Type 1, Type 2 and gestational diabetes that 
occur exclusively in pregnant women (Kim and Amar, 2006). Type 1 usually has its onset 
in childhood and adolescence (Bjelland et al. 2002) and is only prevalent in 5-10% of all 
diabetic patients (Kidambi and Patel, 2008). It is one of the most common chronic 
childhood illnesses affecting 18-20 per 100 000 children in the UK (Devendra et al. 
2004). The term Type 1 diabetes has replaced what was previously known as insulin-
dependent diabetes mellitus (IDDM), juvenile-onset diabetes mellitus (JODM) and early-
onset diabetes (Clark, 2006). The previous names were used because Type 1 diabetics 
needed insulin for life and usually the disease occurred before 30 years of age. The new 
classification is an attempt to introduce appropriate, uniform terminology and to provide 
a functional working classification of diabetes that reflects the current knowledge about 
the disease instead of classification based on treatment methodology (Clark, 2006). 
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The American Diabetes Association recommended that Type 1 DM be further divided 
into Type 1A and Type 1B (Clark, 2006). Type 1A is caused by cell-mediated 
autoimmune destruction of the beta cells of the pancreas while Type 1B refers to non-
immune mediated diabetes (NIMD) with severe insulin deficiency. Type 1B is mainly 
found in people of Asian or African descent. The characteristic features of this Type are 
very similar to those of Type 2 DM which are ketoacidosis and absence of autoimmune 
markers (Clark, 2006; Rees, 2000). 
 
Type 1 diabetes is a slowly progressive T-cell-mediated autoimmune disease (Frier and 
Fisher, 2006; Rees, 2000) although its onset is often abrupt (Kidambi and Patel, 2008, 
Mealey, 2003; Moore et al. 1999; Crawford, 1997). This type of diabetes traditionally 
occurs in individuals younger than 30 years, mostly in adolescence or childhood, but 
according to recent epidemiological studies the incidence seems to be similar in both 
under 30s and adults (Bjelland et al. 2002). In Type 1 diabetes, the beta cells of the Islets 
of Langerhans in the pancreas are destroyed and are unable to produce insulin (Bjelland 
et al. 2002; Kim and Amar, 2006). This results in an inexorable cascade of metabolic 
reactions that eventually manifest as complications associated with diabetes. 
Hyperglycaemia, accompanied by the classical symptoms of diabetes, occurs only when 
70-90% of the beta cells have been destroyed  and this, together with familial studies has 
served as proof that this Type of diabetes has a very slow-onset (Frier and Fisher, 2006).  
 
Insulin is vital for glucose metabolism and the body cannot function well in its absence, 
as it is unable to transport glucose to the cells where it is needed. It facilitates the entry of 
glucose which is already absorbed in the blood stream into the cells of the body by using 
glucose transporters (Mbokazi, 2006). This is the reason why exogenous insulin therapy 
is given to all Type 1 diabetic patients to prevent the build-up of glucose in the tissue 
fluids and blood stream (Bjelland et al. 2002). 
 
Type 1 diabetes often predisposes one to a condition known as diabetic ketoacidosis 
(DKA). DKA occurs as a result of poor insulin control and it interferes with bone 
coupling and healing (Bender and Bender, 2003).  
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When glucose cannot enter the bloodstream, fat is metabolized through lipolysis and this 
is when glycerol and free fatty acids are released. The glycerol is converted to glucose 
and the fatty acids to ketones which then accumulate in the body fluids. Ketones can be 
detected in plasma using dipsticks. A slowly evolving variant of Type 1 diabetes is 
known as latent autoimmune diabetes in adults (LADA). This Type can be detected by 
specific auto antibodies called glutamic acid decarboxylase (GAD) the GAD65Ab being 
specifically associated with LADA in middle-aged people (Frier and Fisher, 2006). This 
subgroup is often masqueraded as Type 2 diabetes until evidence of autoimmune activity 
against pancreatic beta cells is detected. 
 
Type 2 is the most common form of diabetes (King, 2008; Bjelland et al. 2002; Zielinski 
et al. 2002) and it refers to non-insulin –dependant diabetes mellitus. It occurs as a result 
of a reduced responsiveness to insulin or insulin resistance at target organs leading to a 
series of complications which include retinopathy, neuropathy, vascular degeneration and 
nephropathy. While there is still no scientific explanation why the insulin resistance 
occurs in Type 2 patients, it remains well accepted that excessive production of glucose 
in the liver accompanied by under-utilization of glucose in the skeletal muscle result from 
resistance to the actions of insulin (Frier and Fisher, 2006). This Type has its onset above 
40 years of age (Kidambi and Patel, 2008). 
 
In both Type1 and Type 2, the vascular system where the exchange of oxygen, nutrients 
and waste products occurs, is affected. The capillaries are affected in two ways: Firstly, 
they can be damaged due to atheromatous deposits accumulating in the lumen of the 
blood vessels and secondly, they may develop a thickening of the basement membrane 
which reduces the activity of leukocytes. The reduction in the activity of leukocytes leads 
to a reduction in polymorphoneucleocytes’ (PMNs) killing ability making the diabetic 
patient more vulnerable to progress to a more severe infection than what is otherwise 
expected in a non-diabetic patient (Mbokazi, 2006; Bender and Bender, 2003). 
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The accompanying hyperglyceamia causes advanced glycation endproducts (AGEs) and 
the release of glycoheamoglobin (HgbA1c) that also contributes to the thickening of the 
basement membrane of the blood vessels. Unlike hemoglobin, the glycoheamoglobin is 
less adept when it comes to transportation of oxygen. Other pathological mechanisms 
associated to elevated hyperglyceamia are activation of the sorbitol pathway, damaging 
effects of oxidative stress and altered lipid metabolism (Lamster et al. 2008). 
 
Diabetes Mellitus affects the entire body through its medical complications. Tissues 
affected are those rich in blood vessels like the kidney, retina and nerves (Orbak et al. 
2008). Complications such as renal disease, neuropathy, retinopathy, peripheral vascular 
disease and coronary heart disease may occur (Mbokazi, 2006). These serious chronic 
complications are associated with long-term biochemical and functional abnormalities 
that occur in poorly controlled diabetes and they often lead to premature and increased 
morbidity and mortality. The mortality and morbidity occur as a local response to the 
generalized vascular damage that occurs as a result of vascular permeability (Frier and 
Fisher, 2006). At present the annual mortality rate in adult diabetic patients is double that 
of non-diabetic adults as a result of these associated complications (Mbokazi, 2006). 
 
This is largely due to large blood vessel disease which accounts for about 70% of all 
deaths which are mostly from myocardial infarction and stroke. Myocardial infarction is 
the most common cause of death in Type 2 diabetes mellitus (Zielinski et al. 2002). 
Scientific evidence shows that women have a significantly higher risk of morbidity and 
mortality as a result of diabetes associated complications (Gucciardi et al. 2008). 
Gestational diabetes is defined as either onset or first recognition of glucose intolerance 
during pregnancy in a woman that has not had this condition before (Dasanayake et al. 
2008; Kim and Amar, 2006). It occurs in pregnancy and it usually has its onset during the 
third trimester (Mealey, 2003). It is a pernicious condition that is responsible for perinatal 
morbidity and mortality as it is closely linked to pre-eclampsia, caesarian delivery, 
premature rupture of membranes and preterm delivery (Dasanayake et al. 2008). Its 
pathophysiology closely mimics that of Type 2 diabetes as it is associated with increased 
insulin resistance.  
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A diagnosis of this Type of diabetes during pregnancy usually leads to Type 2 diabetes 
within a decade post-delivery which is why gestational diabetes is now seen as a 
harbinger of DM in later life (Kidambi and Patel, 2008). Diagnosis of this condition is 
very significant in order to implement interventions against Type 2 DM and possible fetal 
abnormalities. Apart from the Types of diabetes already discussed, the American 
Diabetes Association has included other Types of diabetes classified according to specific 
etiology or pathophysiology (Kidambi and Patel, 2008; Frier and Fisher, 2006) and these 
are listed in Table 1. 
 
Table 1: Other specific types of diabetes 
 
1 Genetic defects of beta cell function: maturity-onset diabetes of the young 
(MODY) e.g. MODY 1, MODY 2. 
2 Pancreatic disease or injuries (e.g. Pancreatitis, pancreactomy, neoplastic disease,  
etc).  
3 Drug induced diabetes (e.g. corticosteroids, thiazide diuretics, phenytoin and 
nicotinic acid).  
4 Endocrine Disorders: Hyperthyroidism, Cushing’s syndrome, acromegaly, 
pheochromocytocoma, etc. 
5 Other genetic syndromes (Down’s syndrome, Klinefelter’s Syndrome, Turner’s  
Syndrome, etc 
6 Viral infections (e.g. Congenital rubella, mumps, Coxsackie B virus and 
Cytomegalovirus). 
7 Rare Immune Mediated Diabetes Mellitus: stiff man syndrome and anti-insulin 
receptor antibodies. 
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2.2 Risk Factors 
 
Diabetes risk factors can be broadly classified as modifiable and non-modifiable. Those 
that are non-modifiable include factors such as genetic predisposition, increasing age and 
ethnicity (Skamagas et al. 2008). Diabetes Mellitus is associated with familial history 
(Bjelland, 2002), although the mode of inheritance of the susceptible genes is rather 
elusive (Skamagas et al. 2008). The fact that Type 1 diabetes occurs very frequently in 
people of Northern European descent and less commonly in Blacks, Native Americans 
and Asians (Clark, 2006) or that Indigenous Australians have more than twice the 
diabetes prevalence rates compared to the prevalence found in other Australians (Bjelland 
et al. 2002) may be an indication of how ethnicity affects diabetes prevalence. 
 
Modifiable risk factors include obesity, sedentary lifestyles, hypertension, smoking and 
hyperlipidaemia, especially low-density lipoprotein hypercholesterolemia. Changing 
lifestyles characterized by very little exercise and a high fat diet lacking in fibre which 
significantly contributes to obesity (Bjelland et al. 2002; Skamagas et al. 2008). Obesity 
(with a body mass index >30) is a major risk factor for Type 2 diabetes (Bjelland et al. 
2002) as it plays a very significant role in the patho-physiology of diabetes (Ogunbanjo, 
2006). In fact, obesity is an integral part of metabolic syndrome X and it predisposes to 
Type 2 diabetes. According to one study done in South Australia 67.6% of the diabetic 
population were either overweight or obese (Bjelland et al. 2002). Knowledge of these 
risk factors is essential for non-drug management of diabetes. Diabetes often enhances 
the effects of other major cardiovascular risk factors like smoking, hypertension and 
dyslipidaemia (Frier and Fisher, 2006), which is why diabetic patients should receive 
some form of dietary and lifestyle counseling, and should be strongly discouraged from 
smoking and unhealthy eating habits. 
 
Other modifiable risk factors distinctive of diabetes mellitus are impaired glucose 
tolerance (IGT) and impaired fasting glucose (IFG). Both these factors are referred to as 
pre-diabetes. These represent a metabolic state that occurs between diabetes and 
normoglyceamia (Bjelland et al. 2002).  
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People with this condition appear to have worse cardiovascular and mortality outcomes, 
especially those with IGT (Skamagas et al. 2008). To diagnose pre-diabetes, a glucose 
tolerance test has to be done. When carrying out the test, the blood glucose levels are 
measured after the patient has been fasting from the previous night. The patient is given 
an oral dose of glucose and the test is done minutes to hours thereafter (Skamagas et al. 
2008). A fasting glucose value of 100-125mg/dl as well as a post-glucose challenge of 
140-199mg/dl is used to define IFG and IGT respectively (Skamagas et al. 2008). 
 
If a patient is non-diabetic the blood glucose level rises moderately and returns to normal 
ranges within an hour. In diabetic patients the blood glucose levels rise abnormally and 
remain elevated for hours after the oral dose of glucose. The reasons for the prolonged 
hyperglycaemia could either be attributed to a lack of insulin release by the pancreas or 
impaired target tissue response to insulin if not both (Crawford, 1997). Although these 
are not considered as clinical entities, they are important risk factors for developing 
diabetes in the future (Mealey, 2003; Rees, 2000).This is because this prediabetes phase 
represents an active and deleterious phase where progressive beta cell deterioration and 
insulin resistance occurs (Skamagas et al. 2008). 
 
2.3 Epidemiology 
 
Diabetes Mellitus is a common epidemic yet its prevalence is not easy to determine 
because many people remain undiagnosed and many are without any clinical signs and 
symptoms of diabetes (Kapellas and Slade, 2008; Kim and Amar, 2006; Bjelland et al. 
2002). The prevalence of diabetes increases with age has a strong positive correlation to 
obese and overweight individuals. In the year 2000 diabetes was estimated to affect more 
than 171 million people worldwide (Brunton, 2008; Clark, 2006 Mealey, 2003; Crawford, 
1997). World Health Organization currently estimates that more than 180 million people 
have diabetes worldwide (Kirigia et al. 2009). In the United States of America (USA), it 
currently affects more than 12 million people.  
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In the African Region, diabetes was estimated at 7.02 million people in the year 2000. 
and the estimates for 2030 suggest that the prevalence of the disease will increase to 366 
million, most of which will be Type 2 (Brunton, 2008) since it is the most common form 
(Bjelland, 2002).With improvements in treatment, most people are likely to survive for 
longer periods after diagnosis, thereby, further increasing the prevalence  (Ogunbodede, 
2005). 
 
In South Africa (SA), about 4 million people were reported to have diabetes in 2006 
(Clark, 2006).  The prevalence of Type 1 DM varies according to the different socio-
economic groups and geographical location. There seems to be a vast international 
variation in the incidence of Type 1 diabetes. For example, a child in Finland is 40 times 
more likely to develop Type 1 diabetes than a child in Japan and almost 100 times more 
likely to get Type 1 diabetes than a child in the Zunyi Region of China (Devendra et al. 
2004). There is also considerable evidence that a low income also contributes to a higher 
prevalence of diabetes and diabetes related complications (Rabi et al. 2006) and this is 
supported by Velupillai et al (2008), who reported that disadvantaged communities suffer 
higher levels of physical ill health than more advantaged communities. Not only is the 
prevalence and incidence of disease higher in areas of deprivation, but also the nature of 
the problem appears to be qualitatively different; and treatment is less successful 
(Velupillai et al. 2008). People from low-income groups are vulnerable because they have 
poor self-esteem, feelings of helplessness and physical and emotional poverty which all 
play a significant role in their state of health. 
 
Type 1B is commonly found in patients of Asian or African descent (Crawford, 1997). 
Type 2 diabetes accounts for 80-90% of all forms of DM and its prevalence is increasing 
due to increasing obesity patterns (King, 2008). The Pima Indians in Arizona, USA have 
the highest prevalence and incidence rates in the world for Type 2 diabetes (Bjelland, 
2002) followed by the Sardinian populations, with more than 90% of diabetes cases 
(Campus et al. 2005).  The prevalence of Type 2 diabetes is higher in African Americans, 
Native Americans, Hispanics and Pacific Islanders (Mealey, 2003) and it has been 
reported to be between 3-7% in Western countries (Almas et al. 2003).  
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Among Aboriginal Canadians Type 2 diabetes has become an epidemic, with a 
prevalence of 3-5 times higher than non-Aboriginal Canadians (Ley et al. 2009). In South 
Africa, the Indian community has the highest prevalence (10%) followed by the African 
community at 5-6% (Ogunbanjo, 2006).  
 
2.4 Pathophysiology 
 
In order to understand the pathophysiology of diabetes, it is crucial to have a fair 
knowledge of the basic carbohydrate metabolism and insulin action (Mealey, 2003). After 
every meal, there’s an increase in the levels of glucose and insulin is required to regulate 
these levels back to normal. The metabolic regulation of carbohydrates involves not only 
the beta cells, which secrete the insulin that reduces plasma glucose but also the alpha 
cells of the pancreas, the corticoadrenal hormones and the anterior pituitary hormones 
which increase plasma glucose (Zielinski et al. 2002). The hypothesized mechanism 
following ingestion of a high glycaemic carbohydrate is that blood glucose rises quickly, 
as does the secretion of insulin and secretion of insulin continues to bring the blood 
glucose level even lower than the initial glucose level leading to a hypoglycaemic state 
which then triggers the secretion of counterregulatory hormones like glucagon and 
epinephrine which will try to maintain euglyceamia (Janket et al. 2008). 
 
Through this hypoglycaemic state, pathways like glycogenolysis and lipolysis cause an 
abundance release of free fatty acids which we already know to cause insulin resistance. 
Insulin is a hormone that is manufactured and stored in the Islets of Langerhans in the 
pancreas. This hormone plays a significant role in the patho-physiology of diabetes as it 
is the only hormone that lowers blood glucose levels (Mealey, 2003).When there is a rise 
in the blood glucose level the release of this hormone is triggered.  
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Insulin is one of the major anabolic hormones that are vital to the body for the following 
reasons (Crawford, 1997): 
 
1. Transport of glucose and amino acids across membranes 
2. Conversion of glucose into triglycerides 
3. Nucleic acid synthesis 
4. Protein synthesis 
5. Glycogen formation in the liver and skeletal muscles 
 
Its main function is to facilitate glucose transport into special cells of the body at a faster 
rate. These body cells include striated muscle cells, myocardial cells, fibroblasts and fat 
cells (Crawford, 1997). It is implicit therefore that should insulin production and 
secretion be impaired, all blood glucose dynamics will be altered (Mealey, 2003). Insulin 
secretion by beta cells requires glucose transport to enter the cells and that process is 
mediated by glucose transporter-2 (GLUT-2). If for whatever reason insulin production is 
decreased, hyperglycaemia will result, because glucose entry into the blood stream will 
be prevented or slowed-down. If insulin is secreted but not used by the target cells, 
hyperglycaemia will result. 
 
If insulin secretion is increased, blood glucose levels may become too low as more 
glucose will enter the target tissues, leaving very little glucose in the blood stream. This 
will again cause a release of counterregulatory hormones due to prevailing 
hypoglycaemia and with enough repetition of the hyperglycaemia and hypoglycaemia 
cycles; beta cell failure may eventually result, causing Type 2 diabetes mellitus (Janket et 
al. 2008). 
 
2.4.1 Type 1 Diabetes 
 
Type 1 diabetes is both heterogenous and polygenic. In identical twins the relative risk 
for developing diabetes is 33% and the chance of a child developing Type 1 diabetes 
when another first degree relative has diabetes is only 5-10% (Clark, 2006). According to  
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2.4.2 Type 1A 
 
Genetic factors 
Genetic variants or alleles associated with Type 1 diabetes can either cause susceptibility 
to diabetes or can offer protection from diabetes (Devendra et al. 2004; Kidambi and 
Patel, 2008). A combination of genetic and environmental factors is believed to trigger a 
cell-mediated auto-immune attack on beta cells (Crawford, 1997). Genetic factors 
account for about one third of the susceptibility to Type 1 diabetes (Frier and Fisher, 
2006). Diabetes is associated with certain human leukocyte antigens (HLA) which are 
found within the major histo-compatibility complex on the short arm of chromosome 6 
(Frier and Fisher, 2006). The HLADRB1*09 and HLADQB*0302 are associated with 
Type 1 diabetes in black South Africans (Clark, 2006; Crawford, 1997). Type 1A 
diabetes is associated with human leukocyte antigens (HLA), HLA-DR and HLA-DQ and 
is inherited (Crawford, 1997). Most patients who develop Type 1 diabetes either have DR 
3, DQ2 or DR4, DQ8 haplotypes (Devendra et al. 2004). There is a close correlation 
between Type 1 diabetes and other autoimmune conditions; especially thyroid disease 
(Devendra et al. 2004), coeliac disease, Addison’s disease, pernicious anaemia and 
vitiligo (King, 2008; Frier and Fisher, 2006). 
 
Environmental factors 
If a susceptible individual is exposed to an environmental trigger, diabetes may occur. 
These triggers include viruses (enteroviruses, coxsackie and congenital rubella), toxins or 
foods (dietary exposure to non-human proteins in early infancy). The body then responds 
to these triggers through T-cell activation which leads to inflammation whereby 
mononuclear cell infiltration of pancreatic islands takes place. This infiltration is also 
known as insulitis. The beta cell response happens after the insulitis has produced auto 
antibodies to insulin. What results thereafter, is the loss of insulin secretory reserve and 
insulin deficiency (Crawford, 1997). 
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Environmental factors play a critical role in diabetes pathogenesis. It is believed that 
limited exposure to microorganisms during early childhood prevents maturation of the 
immune system and thus predisposes one to autoimmune disease (Frier and Fisher, 2006). 
In certain studies, viral particles known to cause autoimmune damage to beta cells have 
been isolated from pancreatic tissue of diabetic patients serving as evidence that viral 
infection could be an etiological factor for Type 1 diabetes. Viruses such as 
Cytomegalovirus, Epstein-Barr virus, Rubella, Mumps, Retroviruses and Coxsackie B4 
have all been implicated in Type 1 DM. 
 
Dietary factors such as cow’s milk are presumed to trigger Type 1 diabetes (Frier and 
Fisher, 2006) although one study called the diabetes autoimmune study of the young 
(DAISY), where newborns were observed to date, has found no evidence that bovine 
milk ingestion does predispose to diabetes (Devendra et al. 2004). Nitrosamines are 
found in smoked and cured meats and which are found in coffee are also implicated in the 
aetiology of diabetes. 
Stress may also trigger Type 1 diabetes by stimulating the secretion of counter-regulatory 
hormones and modulating immune activity (Frier and Fisher, 2006; Karima et al. 2005). 
During periods of stress, the endogenous production of epinephrine and cortisol causes 
blood glucose levels to be elevated and this can interfere with glyceamic control (Mealey, 
2003). 
 
2.4.3 Type 1B 
This Type of diabetes is not as common as Type 1A and has no known aetiology. Patients 
with this form of diabetes initially present with ketoacidosis, absence of auto-immune 
markers and show physical characteristics which are more common in Type 2 diabetic 
patients. 
 
2.4.4 Type 2 diabetes 
The patho-physiology of Type 2 DM is closely associated with obesity, insulin resistance 
and environmental factors like inactivity and excessive eating (Figure 1). Type 2 diabetes 
is postulated to be a disruption in homeostasis of glucose metabolism (Janket et al. 2008). 
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This Type of diabetes proves to be more complex in nature since it is characterized by a 
combination of insulin resistance and impairment of ß cell function leading to relative 
insulin deficiency (Frier and Fisher, 2006). How these environmental and genetic factors 
interact is still unclear but it is widely accepted that genetic factors do contribute 
significantly to diabetes incidence as shown in Figure 1. 
 
Genes 
Obesity, Beta cell incapacity, insulin resistance, other 
 
                          + 
 
Environment 
Inactivity, abundant food 
         
 
 
Insulin resistance with hyperinsulinaemia 
(Beta cell compensation) 
 
 
 
Beta cell decompensation 
Impaired glucose tolerance 
 
 
 
Decline of Beta cell mass. Severe hyperglyceamia 
Hypoinsulinaemia.Glucotoxicity 
Type 2 diabetes 
 
Fig.  1. Pathogenesis of Type 2 diabetes (Ogunbanjo, 2006). 
 
Similar to Type 1 diabetes, environmental factors interact with genetic factors but the 
underlying genes precipitating environmental factors and pathophysiology differ from 
that of Type 1. Type 2 diabetics are not prone to diabetic ketoacidosis or other metabolic 
imbalances seen in Type 1 diabetics. However, under stressful situations and trauma, 
ketoacidosis may result from the influence of elevated levels of certain stress hormones. 
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Genetic Factors 
Three gene polymorphisms have been identified to be closely associated with Type 2 
diabetes. According to Frier and Fisher (2006) these polymorphisms can increase 
susceptibility by 20%. They are contained in the genes of the PPARγ, Kir6.2 subunit of 
the ß cell KATP channel (Frier and Fisher, 2006). 
 
Environmental Factors 
Obesity and lack of physical exercise are the major contributory factors for Type 2 
diabetes. Individuals with a body mass index >30kg m2 have 10 times more risk of 
developing Type 2 diabetes (Frier and Fisher, 2006). This is in contrast to Type 1 
diabetes which is commonly known as the disease of the lean (Kidambi and Patel, 2008; 
Skamagas et al. 2008). Factors such as genetics, sedentary lifestyle, obesity, and chronic 
inflammation are known to enhance insulin resistance (King, 2008). Type 2 diabetics 
have to pay attention to their diet foods that contain highly refined carbohydrates may 
increase the demand for insulin secretion (Janket et al. 2008). 
 
Apart from hyperglyceamia, Type 2 diabetes patients have a group of disorders which are 
called metabolic syndrome X. This syndrome is characterized by the following: 
abdominal obesity, atherogenic dyslipidaemia, raised blood pressure, Insulin resistance 
(with or without glucose intolerance), pro-inflammatory state and prothrombin state. All 
these conditions predispose to cardiovascular disease (Ley et al. 2009).  
 
The incidence of Type 2 diabetes is increasing at the same time that the overweight and 
obesity profiles are increasing (Brunton, 2008). In Type 2 diabetic patients, visceral 
abdominal fat tissue is metabolically active, and this generates large quantities of free 
fatty acids (FFA). They induce insulin resistance because they compete with glucose as a 
fuel supply for oxidation in peripheral tissues such as muscle (Janket et al. 2008; Frier 
and Fisher, 2006). The cytokines generated by the visceral abdominal fat are called 
adipokines and are strongly associated with insulin resistance, diabetes, hypertension and 
dyslipidemia which all significantly increase the risk of microvascular and macrovascular 
complications (Skamagas et al. 2008). 
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2.5 Pathogenesis 
 
Inflammation and oxidative stress are important factors in the pathogenesis of diabetes 
and they both contribute to the pathogenesis of diabetic complications (Ding et al. 2007). 
In addition, advanced glycation endproducts (AGEs) formation is considered to be major 
causal factors for the pathogenesis of diabetes complications (Taylor and Borgnakke, 
2008). However, the pathogenesis is much more complex and involves a series of 
interrelated metabolic changes which gradually lead to the diagnosis of diabetes. 
 
2.5.1 Type 1 diabetes 
 
Insulitis (infiltration of the islets with mononuclear cells containing activated 
macrophages, helper cytotoxic and suppressor T lymphocyte) or the selective destruction 
of insulin-producing cells in the pancreas is the hallmark of Type 1 diabetes (Devendra et 
al. 2004). T-cell abnormalies are believed to be the major cause of autoimmune disease in 
Type 1 diabetes, leading to the destruction of pancreatic islets (King, 2008). This 
autoimmune destruction of pancreatic cells is the main reason behind the insulin 
deficiency that occurs in Type 1 diabetes but conditions such as pancreatitis and surgical 
removal or destruction through cystic fibrosis will lead to insulin deficiency too (Kidambi 
and Patel, 2008). 
 
There is evidence to suggest no involvement of Type 1 diabetes to autoantibodies 
contrary to the belief that expression of diabetes-related autoantibodies in young children 
will serve as a major risk factor to the development of Type 1 diabetes (Devendra et al. 
2004). Beta cell destruction is associated with the following cells: CD4, CD8, T 
lymphocytes and macrophages. These events eventually lead to loss of the first phase 
insulin response (Devendra et al. 2004).  Once the beta cells are destroyed, the classic “3 
P” symptoms known as polydipsia, polyuria and polyphagia appear (Bender and Bender, 
2003).Type 1 diabetes has a strong genetic predisposition (Kidambi and Patel, 2008). 
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2.5.2 Type 2 diabetes 
 
Type 2 diabetes is preceded by insulin resistance and the target tissues have a decreased 
response to the normal levels of circulating insulin (Kidambi and Patel, 2008). Patients 
with Type 2 diabetes have a slow-onset of relative insulin deficiency (Frier and Fisher, 
2006). The results are that more and more insulin is required by the target tissues 
therefore hyperinsulinemia occurs. 
 
The genetic predisposition for Type 2 diabetes is much stronger than for Type 1 diabetes 
(Kidambi and Patel, 2008). In a study conducted by Das and Rao (2007) it was observed 
that genes involved in carbohydrate, lipid and amino acid metabolism pathways, glycan 
of biosynthesis, metabolism of cofactors and vitamin pathways, ubiquitin mediated 
proteolysis, signal transduction pathways, neuroactive ligand-receptor interactions, 
nervous system pathways and neurodegenerative disorder pathways are upregulated in 
obesity compared to health subjects. This study further identified that genes involved in 
signal transduction, regulation of actin cytoskeleton, complement and coagulation 
cascades were upregulated in subjects with Type 2 diabetes.  
 
These findings therefore suggest that genes involved in carbohydrate metabolism, lipid 
and amino acid metabolic pathways and inflammation have a significant role in the 
pathogenesis of Type 2 diabetes (Das and Rao, 2007).  In these patients hyperglycaemia 
develops gradually over a long period and the renal threshold (capacity of renal tubules to 
reabsorb glucose from the glomerular filtrate) for glucose rises, so that osmotic symptoms 
(polyuria and polydipsia) are usually mild (Frier and Fisher, 2006). Type 2 DM is also 
associated with dyslipidaemia. Obesity and Type 2 diabetes are characterized by chronic 
oxidative stress and inflammatory stress (Brunton, 2008). 
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2.6 Diagnosis 
 
Diagnosing Diabetes Mellitus is the realm of the physician (Mealey, 2003) as dentists are 
not qualified to make a diagnosis (Vernillo, 2003). However, it is still important for 
dentists to understand how the diagnosis is reached since they have a significant role to 
play in identifying those individuals at risk or who may have undiagnosed DM. The 
American Diabetes Association has endorsed the screening of all those who are at risk for 
diabetes and all those above 45 years of age (Skamagas et al. 2008). 
 
Several tests are used in order to diagnose DM but the primary methods are fasting 
venous plasma glucose levels and oral glucose tolerance tests (Bjelland et al. 2002). 
Generally, a fasting glucose test is used as a way of screening patients but it remains 
limited since it cannot detect all forms of diabetes. A fasting glucose of 126mg dl-1 or 
more is used to distinguish a diabetic patient (Skamagas et al. 2008). 
 
A post oral glucose challenge value of 200mg dl-1 or more is another way of 
distinguishing a diabetic patient. When the above tests have been done and a diabetic 
patient is distinguished, the next step is to do an oral glucose tolerance test (OGTT) for 
those who had impaired fasting glucose or in a high-risk individual with a normal fasting 
glucose. In the past, oral glucose tolerance test used to give false positive results  as a 
result of stress-induced adrenaline release which impairs the response to glucose loading 
and this is why this test is not as popular anymore (Bjelland et al. 2002). For this test the 
readings are taken twice; one reading at baseline and another 2 hours after ingesting a 75g 
load of glucose. Should two abnormal readings be taken on different days then it’s 
undeniably a case of diabetes (Skamagas et al. 2008). 
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2.7 Medical complications of Diabetes Mellitus 
 
Diabetes complications have important effects on the patients’ quality of life 
(Papadopoulos et al. 2007) and in order to improve the quality of life of diabetic patients 
it is important to understand these complications. The most common complications are 
retinopathy, neuropathy, cardiovascular disease, peripheral vascular disease and 
periodontal disease (King, 2008). Organs and tissues which have abundant capillary 
vessels are the ones which are severely affected by diabetes due to the changes that take 
place in the capillary basement membrane. In Type 1 diabetes the common complications 
are as a result of microvascular disease while in Type 2 diabetes both microvascular and 
macrovascular disease cause complications (Kidambi and Patel, 2008). Most 
complications associated with diabetes will occur secondary to the development of 
microangiopathy. The histopathological hallmark of diabetic microangiopathy is the 
thickening of the capillary basement membrane with associated increased vascular 
permeability throughout the body (Frier and Fisher, 2006). 
 
Metabolic control is directly responsible for the extent or severity of diabetic 
complications that a diabetic individual will present with, but factors like the patients’ 
socio-economic status and the duration of diabetes play an even bigger role. These 
complications present as diseases of small blood vessels (microangiopathy) or disease of 
large blood vessels (macrovascular). Microangiopathy causes morbidity and disability 
through conditions such as blindness due to diabetic retinopathy, difficulty in walking, 
chronic ulceration of the feet, and bowel and bladder dysfunction (Frier and Fisher, 
2006). Macrovascular complications lead to morbidity through myocardial infarction, 
stroke, angina, cardiac failure and intermittent claudication (Frier and Fisher, 2006). 
Almost three quarters of the diabetic population develop cardiovascular disease and die 
from cardiovascular complications (Janket et al. 2008).Vascular problems increase 
anaerobic infection (Bender and Bender, 2003). Metabolic syndrome X and Type 2 
diabetes resulting from sustained hyperglycaemia are also considered risk factors for 
cardiovascular disease although their mechanism in cardiopathogenesis has not been 
clearly outlined (Janket et al. 2008).  
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Another common complication is called atherosclerosis. Increased lipid deposition and 
atheroma formation is seen in the larger blood vessels coupled with increased thickness 
of arterial walls (Mealey, 2003). The pathological changes associated with atherosclerosis 
in diabetic patients are no different from those observed in non-diabetic patients, it is just 
that in diabetics they occur much earlier in life and are more severe (Frier and Fisher, 
2006). They can be exacerbated by the presence of other risk factors such as smoking, 
hypertension and dyslipidemia (Kidambi and Patel, 2008). Due to the insidious nature of 
Type 2 diabetes patients are often diagnosed too late, when most of the damage to tissues 
and organs has been done. As a result a lot of pathological changes may be detected in 
more than one organ. 
 
Manifestations of diabetes complications may be detected in a patient who is not known 
to have diabetes and this may well lead to the patient being diagnosed with diabetes 
following a comprehensive investigation testing blood glucose levels. On the contrary, 
Type 1 diabetes is characterized by abrupt onset of symptoms, decreased insulin in the 
serum, dependence on exogenous insulin and a tendency for ketosis (Murrah, 1985). 
Patients with Type 1 diabetes are especially susceptible to microvascular complications 
like neuropathy, retinopathy and nephropathy. 
 
Diabetes Mellitus also affects joint function as well as bone density and dentists should 
be cognizant of this when treating diabetic patients. The increased stiffness and loss of 
flexibility detected in diabetic patients may affect the functioning temporomandibular 
joint (TMJ) (Kidambi and Patel, 2008). There are 2 possible mechanisms for the 
complications of diabetes - firstly the polyol pathway ensures that glucose is reduced to 
sorbitol (a tissue toxin) by the enzyme aldol reductase and secondly the production of 
advanced glycation endproducts (AGEs) through the non-enzymatic addition of hexoses 
to proteins. This leads to alterations of many body proteins like collagen, haemoglobin, 
lipoproteins and their functions (Soskolne, 1998). 
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2.8 Management of Diabetes Mellitus 
 
The rationale behind the management of diabetes mellitus is to keep blood glucose levels 
as close to normal as possible so as to prevent microvascular and macrovascular 
complications of diabetes. Diabetes complications have significant effects on patients’ 
quality of life  which is why the guidelines for treatment of Type 2 DM emphasize that 
one of the primary objectives is to improve health related quality of life (HRQOL) 
(Papadopoulos et al. 2007). 
 
There is considerable evidence to show that it is possible to reverse microvascular disease 
if early interventions are pursued and this is supported in part by Tan et al (2006), who 
reported that early diagnosis and aggressive treatment of the disease can delay or prevent 
progression of the major chronic complications. Strict glycaemic control has been shown 
to reduce microvascular complications in Type 1 diabetes (Skamagas et al. 2008). 
 
Although no cure exists for diabetes, the disease can and its complications can be 
prevented, delayed and managed by identifying risk factors and detecting the condition at 
an early stage (Ley et al. 2009). The Diabetes Control and Complications Trial (DCCT) 
which lasted 9 years demonstrated strong evidence of a 60% overall reduction in the risk 
of developing diabetic complications in those patients on intensive therapy with strict 
glyceamic control (mean HbA1c around 9%) (Skamagas et al. 2008; Frier and Fisher, 
2006). 
 
The United Kingdom Prospective Diabetes Study (UKPDS) also showed that diabetic 
complications and progression thereof is much slower with good glyceamic control and 
effective treatment of hypertension, irrespective of the Type of therapy used (Frier and 
Fisher, 2006). There are different methods of treatment that can be used to treat diabetes 
ranging from diet modification and lifestyle changes, oral antidiabetic drugs to insulin. 
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2.8.1. Non Drug Management 
 
2.8.1.1 Diet and lifestyle changes 
 
Diet control is the first vital step in individuals with Type 2 diabetes with the aim of 
reducing the intake of refined sugar and high lipid containing foods (Bjelland et al. 2002). 
The recommended diet should contain 50-65% carbohydrate, 30% total fat with saturated 
fat being less than 10% and 10-20% of protein (Ogunbanjo, 2006). Patients may be 
advised to lose weight and to engage in physical exercise to reduce their BMI. The 
recommended exercise regime is moderate intensity physical exercise of at least 150 
min/week or intense aerobic activity for at least 90 min/week with not more than 2 
consecutive days of not exercising (Clark, 2006). Patients should be discouraged from 
alcohol consumption as well as smoking since these are known risk factors for diabetes. 
If good glyceamic control is not achieved by dietary modification and lifestyle 
modification alone, oral anti-diabetic drugs may be used (Frier and Fisher, 2006). 
 
2.8.2 Drug therapy 
 
Oral hypoglyceamics 
The use of oral hypoglycaemic drugs is very common in treatment of Type 2 diabetes. 
The aim of these drugs is to promote insulin release from the pancreas, encourage insulin 
uptake in the target organs and suppress appetite (Bjelland et al. 2002). 
This mode of treatment was previously limited to sulfonylureas, pork and beef insulins 
and metformin but advances in medicine have led to new classes of oral medication, 
injectable medication recombinant human insulins and novel insulin delivery systems 
(Skamagas et al. 2008; Kidambi and Patel, 2008). 
 
Metformin, a biguanide is the drug of choice for patients who are younger than 80 years 
and who have no end organ disease. Its mechanism of action is prevention of hepatic 
gluconeogenesis and improving insulin sensitivity in muscle and adipose tissue 
(Skamagas et al. 2008).  
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Oral biguanides are also used in overweight patients with normal renal function due to 
their anorexic effects. Sulfonylureas which are insulin secretagogues are prescribed for 
other Type 2 diabetes mellitus patients. They act by binding to sulfonylurea receptors on 
the beta cells triggering the release of insulin (Kidambi and Patel, 2008). They can lower 
the HbA1c but often lead to hypoglyceamia and weight gain. 
 
Thiazolidinediones (TZD) including pioglitazones and rosiglitazone act by increasing 
tissue sensitivity to insulin and by decreasing blood glucose levels (Mealey, 2003). They 
do not however cause hypoglyceamia. Their mechanism of action is through activation of 
peroximose proliferator-activated receptor γ to affect glucose and lipid metabolism 
(Kidambi and Patel, 2008). In recent years this drug was believed to have anti-
inflammatory effects and to have the ability to preserve beta cells but the data generated 
in clinical trials only proved its enhanced insulin sensitivity effect (Skamagas et al. 2008). 
Its side effects include fluid retention and weight gain (Skamagas et al. 2008) and in 
susceptible people it may precipitate congestive heart failure and increase the risk of bone 
loss (Kidambi and Patel, 2008). 
 
Arcabose can inhibit intestinal enzymes that metabolize carbohydrates into 
monosaccharides and this leads to a delay in carbohydrate absorption (Skamagas et al. 
2008; Mealey, 2003). This agent inhibits α-glucosidase in the stomach which then 
prevents the breakdown of some complex carbohydrates into simple sugars making them 
inabsorbable (Kidambi and Patel, 2008).They often have gastrointestinal side-effects like 
flatulence and diarrhea. 
 
Incretins are the newest group of oral agents for treatment of Type 2 diabetes and as such, 
they target the incretin pathway. They act by inhibiting the rapid breakdown of two 
intestinally secreted hormones (glucagon-like-peptide-1 and gastric inhibitory peptide) 
which are released following a meal (Kidambi and Patel, 2008).They increase insulin 
secretion, decrease glucagon secretion and delay gastric emptying (Kidambi and Patel, 
2008; Frier and Fisher, 2006). 
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Insulin therapy 
 
More often than not, good glyceamic goals are not met by most of these oral 
hypoglyceamic drugs and that leads to insulin therapy being introduced. Insulin therapy 
may be initiated if there is end organ disease or if the side effects that prevent the use of 
oral medication in severely uncontrolled Type 2 diabetes and Type 2 patients with 
reduced insulin production. In this case basal insulin or long-acting insulin is used to 
normalize fasting glucose in the morning (Skamagas et al. 2008). Glargine and Detemir 
are ideal since they are long acting. 
 
For Type 1 diabetes insulin is the mainstay of treatment (Kidambi and Patel, 2008). 
Physiologic insulins are used and they can be administered by multiple injections with a 
basal-bolus regimen, or continuous subcutaneous insulin injection using an insulin pump 
(Kidambi and Patel, 2008; Skamagas et al. 2008). There are different Types of insulin 
preparations varying from short-acting, mediate-acting to long-acting. Modern insulin 
therapy combines the use of short-acting, rapid onset insulin with longer acting forms so 
that glucose levels are maintained with minimal peaks and troughs through the day 
(Bjelland et al. 2002). In South Africa all insulin varieties are biosynthetic (Clark, 2006). 
Insulin therapy should also mimic the physiological release of insulin, which is 
characterized by a continuous basal secretion, to prevent fasting hyperglyceamia, as well 
as prandial insulin release to prevent postprandial hyperglyceamia (Kidambi and Patel, 
2008). 
 
The success of this therapy bases itself on the ability of patients to monitor their own 
blood glucose levels with the use of glucometers. This will allow the patients to adjust 
their insulin dose, diet and exercise to produce normoglyceamia and prevent 
hypoglyceamia (Kidambi and Patel, 2008). 
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Combined oral anti-diabetic drug and insulin 
 
In certain instances a diabetic patient may need increasing doses of a sulfonylurea or 
biguanide, either alone or in combination with each other or with a thiazolidinedione, the 
introduction of a single dose of intermediate- or long-acting insulin, administered at 
bedtime, may improve glyceamic control (Frier and Fisher, 2006). 
 
2.8.3 Control of other risk factors 
 
Certain randomized clinical trials have proved that aggressive management of lipids and 
blood pressure is beneficial in managing diabetes mellitus (Frier and Fisher, 2006). The 
use of ACE-inhibitors is recommended for its ability to improve outcomes in heart 
disease and in preventing diabetic nephropathy (Skamagas et al. 2008, Frier and Fisher, 
2006). Also, smoking is a risk indicator for periodontal disease in diabetic patients (Tan 
et al. 2006). Smokers are therefore at a high risk for developing more periodontitis than 
non-smokers (Wilkins, 1999). Delayed wound healing after surgical and non surgical 
procedures may be a common finding in those patients who are smokers. Due to these 
reasons, an effort should be made to advise patients to stop smoking and to effectively 
treat hypertension and dyslipidemia. Alcohol, which is another risk factor for diabetes,  
can raise blood pressure and contribute to other health problems so its use by a diabetic 
patient should be discouraged (Wilkins, 1999). 
 
2.8.4 Patient Education 
 
Apart from the pharmaceutical preparations used to treat diabetes, patient education still 
plays a significant role in management of a diabetic patient. Diabetes can be a fairly 
complex disease to comprehend and as such, it is crucial that patients are made to 
comprehensively understand the very nature of diabetes so that they know how to cope 
with any given complications.  
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Those on insulin need to learn to measure their dose correctly and to administer the 
insulin to themselves on the basis of blood glucose values and other factors like exercise, 
illness and episodic hypoglyceamia (Frier and Fisher, 2006). Diabetic patients should be 
advised to carry a card with information on their name, address, their diabetes status, the 
nature and dosage of their drug treatment and the particulars of their physician in case 
there is an emergency where the patient is unconscious  (Frier and Fisher, 2006). 
 
2.8.5 Self-assessment of glyceamic control 
 
Patients should be taught to perform capillary blood glucose measurements using blood 
glucose test strips. The recommended targets for adults are pre-prandial capillary plasma 
glucose of 5.0-7.2.mmol/l and peak postprandial capillary plasma of <10.0.mmol/l 
(Clark, 2006).This step has an added advantage that information on glucose levels is 
readily available and the patient can thus adjust treatment appropriately (Frier and Fisher, 
2006). 
 
2.9 Diabetes and the oral cavity 
 
Similar changes to those that occur in the kidney, nerves and retina also take place in the 
oral mucosa. Oral health complications associated with diabetes include xerostomia, 
tooth loss, gingivitis, periodontitis, odontogenic abscesses, caries and soft tissue lesions 
of the tongue and mucosa (Vernillo, 2003; Moore et al.1999; Moore et al. 1998). Burning 
mouth syndrome, poor wound healing and an increased incidence of acute oral infection 
are all very common features in diabetic patients. Oral complications are more 
pronounced and occur more readily in Type 1 uncontrolled DM than in Type 2 subjects 
(Vernillo, 2003).  
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2.9.1 Xerostomia 
 
Xerostomia is a commonly reported oral complication in the diabetic patient (Murrah, 
1985) and is attributed to a decrease in salivary flow. Approximately one in five adults 
report having xerostomia (Thomson et al. 2006). It is associated with polyuria which is 
also commonly experienced by diabetic patients. It is not clear whether xerostomia occurs 
as a result of the diabetes or due to the medication used in treatment.  
 
In some patients xerostomia may present with an enlargement of the parotid glands 
(Mealey, 2003). The changes in the salivary secretion are believed to occur as a result of 
the accompanying neuropathy of the autonomic nervous system and this alters the normal 
oral cavity environment thus predisposing a healthy mouth to dental caries (Vernillo, 
2003). Dryness of the mouth may lead to oral tissues being more susceptible to trauma 
and opportunistic infections such as Candida but also an increased accumulation of 
bacterial plaque and food debris that contributes to dental caries and periodontal disease 
(Rees, 2000). Xerostomia may be associated with difficulties in chewing, swallowing, 
tasting and speaking which leads to poor dietary intake, malnutrition and poor 
socialization (Soell et al. 2007). It has recently been shown to affect the oral health-
related quality of life (Thomson et al. 2006). 
 
2.9.2 Candida 
 
Oral candidiasis is commonly found in diabetics and it is believed to occur due to the 
dryness of the mucosa. This opportunistic fungal infection is caused by Candida albicans 
and is commonly associated with hyperglyceamia. It is often associated with marginally 
or uncontrolled diabetes and has a positive correlation to salivary gland dysfunction 
(Vernillo, 2003; Soell et al. 2007). Its occurrence in the diabetic patient may well be 
attributed to the fact that diabetics have impaired immune defense mechanisms and that 
makes them more susceptible to infection (Bjelland et al. 2002). 
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2.9.3 Burning mouth sensation 
 
This condition is of unknown aetiology but is closely associated with salivary gland 
dysfunction, candidiasis and neurological abnormalities such as depression (Vernillo, 
2003). Patients experiencing a burning mouth sensation do not present with any 
detectable lesion except the symptoms of pain and a burning sensation on the tongue. It is 
also suggested with no definite proof that this condition is common in severe diabetes 
mellitus where diabetic neuropathy exists as a complication (Rees, 2000). 
 
By definition, gingivitis is a condition where inflamed gingival tissues are associated with 
a tooth, with no attachment loss or with previous attachment and bone loss, but is not 
currently losing attachment or bone (Tan et al. 2006). This is the most prevalent mild 
form of periodontal disease which is characterized by inflammation of the gums, 
erythema, swelling and frequent bleeding (Kim and Amar, 2006).  
 
This inflammation of the gingiva is caused by bacterial plaque accumulation and is 
reversible if treatment is initiated early enough (Soell et al. 2007). Gingival bleeding is an 
indicator of inflammation and it is possible that the vascular changes that take place in the 
diabetic patient enhance this bleeding (Orbak et al. 2008). Apart from the microvascular 
changes leading to gingival bleeding, there’s a correlation of gingiva with accumulation 
of plaque and calculus which act as local irritants to the gingival, leading to inflammation 
of the gums (Orbak et al. 2008). Increased salivary glucose may also contribute to the 
inflammatory process by way of increased bacterial substrate and plaque formation 
(Vernillo, 2003). 
 
2.9.5 Periodontitis 
 
Periodontitis is defined as an inflammatory disease of the supporting tissues of the teeth 
caused by specific microorganisms or groups of specific microorganisms resulting in 
progressive destruction of the periodontal ligament and alveolar bone with pocket 
formation, recession or both (Tan et al. 2006).  
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This condition is now classified as the 6th most common complication of diabetes 
(Kidambi and Patel, 2008; Almas et al. 2003; Vernillo, 2003; Zielinski et al. 2002) after 
retinopathy, nephropathy, neuropathy, peripheral vascular disease and cardiovascular 
disease. It is often referred to as the 6th “opathy” of diabetes (Mansour and Abd-Al-sada, 
2005).  
 
Periodontitis is a bacterial infection caused by Gram-negative anaerobes found in the 
subgingival plaque. The most commonly implicated bacteria causing periodontitis are 
Porphyromonas gingivalis, Prevottella intermedia, Tannerella forsythensis and 
Treponema denticola (Soell et al. 2007). 
This is an infection characterized by oxidative stress, a factor which plays a major role in 
diabetic vascular complications (Karima et al. 2005). In a diabetic patient, periodontitis is 
presumed to occur due to an exaggerated inflammatory response to the periodontal micro 
flora (Lamster et al. 2008). This causes a chronic inflammatory condition characterized 
by loss of connective tissue attachment and alveolar bone height (Almas et al. 2003). The 
incidence and severity of periodontitis is influenced by the presence or absence of 
diabetes mellitus as well as the degree to which the disease is controlled by the patient 
(Tan et al. 2006; Mealey, 2003; Rees, 2000).  
 
While periodontal infections have an impact on diabetic control, diabetes is a major risk 
factor for the development of periodontal disease (Wilder et al. 2009; Tan et al. 2006; 
Karima et al. 2005) and this is underpinned by epidemiological studies and case reports 
(Tan et al. 2006).This explains the reciprocal relationship that exists between diabetes 
and periodontitis. In fact, there’s evidence to suggest that periodontal disease may 
increase the risk of experiencing poor metabolic control (Lamster et al. 2008) or that 
periodontal disease has the potential to have adverse impact on glycaemic control in 
patients with diabetes mellitus (Herring and Shah, 2006). 
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Periodontitis is a very common feature in diabetes and it becomes even more severe as 
the diabetic state progresses (Moore et al. 1999). In one meta-analysis of 18 comparative 
cross-sectional studies, subjects with diabetes had substantially more severe periodontal 
disease when compared to healthy subjects (Wilder et al. 2009). Unequivocally, diabetes 
impairs the immune system’s defense mechanisms making diabetic patients not only 
more susceptible to infections but also the manifestations of those infections being more 
severe in comparison to non-diabetic patients (Bjelland et al. 2002). Periodontitis as a 
complication of diabetes is believed to occur following a series of exaggerated 
inflammatory response to the periodontal micro flora (Lamster et al. 2008). This belief is 
supported, in part, by the findings that there seems to be no difference in subgingival 
micro flora between periodontitis patients and their non-diabetic counterparts (Campus et 
al. 2005). Factors that increase the severity of inflammatory disease like neutrophil 
dysfunction have been associated with the pathogenesis of diabetes. Periodontal damage 
in diabetics is initiated by microbial plaque and the prevailing hyperglyceamia. 
 
In a hyperglycaemic environment, proteins like collagen undergo a glycosylation process 
to form advanced glycation end products (AGEs), which play a significant role in 
periodontal tissue destruction (Tan et al. 2006). The deterioration in the patient’s 
periodontal health which occurs as a result often presents as deep pockets and tooth 
mobility often resulting in teeth being extracted. After the extraction the quality of life of 
an individual is affected as patients cannot chew their foods resulting in unhealthy eating 
habits and consumption of less fibre-rich foods and more refined carbohydrates. This is 
supported by Moore et al (1999) who reports that periodontal disease and tooth loss may 
impact on overall health by compromising a patient’s ability to maintain a healthy diet 
and proper glyceamic control. 
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Mechanism of action 
 
Development of periodontitis occurs as a result of many factors including the microbial 
challenge, genetic risk factors, environmental factors and acquired risk factors (Tan et al. 
2006). The thickening of the basement membrane which occurs as a result of 
hyperglycaemia in diabetes alters the oxygen diffusion, waste elimination, leukocyte 
migration and the diffusion of immune factors. These alterations may all contribute to the 
pathogenesis of periodontitis (Bjelland et al. 2002).  
 
In a hyperglycaemic environment, proteins like collagen undergo a glycosylation process 
to form advanced glycation end-products (AGE) (Tan et al. 2006). Greater vascular 
permeability in AGE-enriched gingival tissue will lead to greater breakdown of collagen 
fibres and accelerated destruction of both connective tissue and bone (Mansour and Abd-
Al-sada, 2005).  
 
Infection in diabetics become more severe and last longer because of neutrophil 
microbicidal suppression and synergism of aerobic and anaerobic bacteria, as a result of 
the reduced oxygen diffusion across capillary walls causing anoxia (Bender and Bender, 
2003). In a diabetic patient advanced glycation endproducts (AGEs) are the first 
byproduct to form once there’s excess glucose which has come into contact with 
structural proteins. These AGEs then bind to cellular receptors, which are found on 
endothelial cells and monocytes, known as RAGE. Once the AGE-RAGE complex has 
formed, it triggers certain proinflammatory events which lead to accelerated destruction 
of connective tissue and bone in a diabetic patient (Lamster et al. 2008). AGE is also 
believed to affect wound healing by inducing apoptosis of extracellular matrix producing 
cells (Taylor and Borgnakke, 2008). 
 
In addition to the proinflammatory responses, other pathophysiologic changes like 
reduction in leukocyte chemotaxis, phagocytosis, apoptosis, serum opsonic activity and 
reduced cellular immunity may predispose diabetic patients to periodontitis. The 
depressed immune response resulting from diabetes may explain why it may not be 
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possible to totally eradicate periodontal infection in a diabetic patient, even after 
conventional periodontal therapy (Tan et al. 2006). During the inflammatory process, 
neutrophils are stimulated to produce large quantities of superoxide and hydrogen 
peroxide which are both naturally occurring chemicals within the neutrophil. This process 
is catalyzed by an oxidative complex known as NADPH and this pathway results in 
increased oxidative stress which has been shown to significantly contribute to 
periodontitis (Karima et al. 2005). 
 
The inflammed periodontal tissue also releases cytokines similar to those released by the 
visceral abdominal fat tissue and they are made up of tissue necrosis factor-alpha (TNF-
α) and Interleukin-6 (IL-6) and they both may contribute to aggravate diabetes (Skamagas 
et al. 2008). It has been postulated that gingival crevicular fluid neutrophil elastase 
activity, age and smoking are all risk indicators for periodontal disease in diabetic 
patients (Tan et al. 2006). Enzyme ß-glucoronidase is a lysosomal enzyme which is also 
released during the inflammatory process when degranulation of PMNs takes place (Tan 
et al. 2006). It is also believed that the release of reactive oxygen species activates 
metalloproteinase, which degrade the collagen in the ligaments thus causing loss of 
attachment on the tooth (Herring and Shah, 2006). 
 
2.9.6 Dental Caries 
 
There seems to be no evidence linking diabetes mellitus to dental caries and information 
that has been published has often lacked consistency (Soell et al. 2007; Zielinski et al. 
2002). Perhaps this inconsistency is as a result of different behavioural patterns among 
diabetic patients, where those that are compliant and motivated will engage in good oral 
hygiene practices and stick to regular dental appointments as opposed to those that are 
non-compliant. Since most diabetic patients limit their intake of fermentable 
carbohydrates, the less cariogenic diet may limit caries incidence (Mealey, 2003). There 
are reports of increased incidence of dental caries among uncontrolled or marginally 
controlled diabetes mellitus in both animals and human studies (Rees, 2000).  
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2.9.7 Salivary Dysfunction 
 
This condition is difficult to diagnose since decreased salivary flow may occur as a result 
of factors like medication, age, neuropathy and thirst. However, this is a common finding 
in diabetic patients. It is associated with xerostomia and may lead to dryness of the 
mucosa and may contribute to dental caries formation. It is often accompanied by 
mucositis, ulcers and desquamation and often the tongue is inflamed and depapillated 
(Vernillo, 2003). 
 
2.9.8 Altered taste sensation 
 
The change in taste has been attributed to altered glucose receptors or early manifestation 
of diabetic neuropathy (Bender and Bender, 2003). Taste strongly influences food 
preference and intake and taste receptor variants have been associated with differences in 
taste perception (Dotson et al. 2008). It has also been attributed to xerostomia and 
candidiasis (Boyce and Shone, 2006); as a direct result of diabetic neuropathy or 
medication. Decreased taste sensation may be more pronounced for sucrose as opposed to 
other taste tests, and this indicates a direct effect of diabetes mellitus (Rees, 2000). The 
taste receptors involved are the TAS1R and TAS2R and they are responsible for sweet 
and bitter taste stimuli respectively (Dotson et al. 2008). There’s a belief that altered taste 
sensation is an age-related phenomenon. One theory is that normal ageing produces taste 
loss because of changes in taste cell membranes involving altered function of ion 
channels and receptors (Boyle and Shone, 2006). This condition has been reported in 
diabetes patients who receive hemodialysis (Lamster et al. 2008). 
 
2.9.9 Acute oral infections 
 
This refers to recurrent episodes of herpes simplex virus, periodontal abscesses and 
palatal ulcers that occur in marginally controlled diabetics (Vernillo, 2003). These 
infections are believed to occur as a result of the same pathogenic mechanism which is 
associated with increased susceptibility to periodontal infections (Vernillo, 2003). 
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2.10 Management of oral complications 
 
2.10.1 Management of xerostomia 
 
Treatment of xerostomia is essential to encourage salivary stimulation to keep the mouth 
moist, prevent caries and Candida infection to provide palliative relief (Vernillo, 2003). 
The use of saliva substitutes and stimulants is recommended for this purpose. Artificial 
saliva containing methylcellulose or a mucin base can be used. Patients could also be 
encouraged to use sugarless chewing gum to stimulate salivary flow. Topical fluorides 
should be used so as to prevent caries. 
 
2.10.2 Management of candidiasis 
 
It is crucial for the dentist to remember the association of candidiasis with marginally or 
uncontrolled diabetes and the positive correlation to salivary gland dysfunction as this 
information will influence the drug of choice for a patient. As a precautionary measure a 
dentist should assess the sugar content of the intended medication (Vernillo, 2003) so as 
to not contribute to the hyperglycaemic state of the patient. Topical and systemic agents 
are available for treatment of candidiasis. Some of these preparations contain 
corticosteroids that provide both anti-inflammatory and anti-pruritic benefits, however, 
steroids can potentially cause hyperglyceamia due to their antagonistic effect on the 
action of insulin (Vernillo, 2003). The following treatment options are available for these 
patients (Vernillo, 2003): 
 
0.5% gentian violet aqueous solution applied topically in the mouth 3 times a day. 
Nystatin vaginal suppositories-although this preparation is not designed for oral use, 
clinicians have found it useful in treatment of oral candidiasis when the sugar content of 
other topical antifungal medications is a concern (Vernillo, 2003). 
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Clotrimazole troches given as 1-10mg troche 5 times/day for 2 weeks. These troches have 
a very high sugar content and should be used with caution so as not to affect glycaemic 
control. 
Fluconazole 100mg/day for 2 weeks  
Ketaconazole 200mg/day for 2 weeks  
Itraconazole 200mg/day for 2 weeks. This drug is effective against resistant strains of 
Candida albicans. 
 
2.10.3 Management of burning mouth syndrome 
 
Due to its association with xerostomia and Candida, some relief may be achieved through 
proper management of these two factors. In uncontrolled diabetes it is recommended that 
the glyceamic control be improved so as to prevent complications associated with 
hyperglyceamia.  Agents  such  as  benzodiazepines,  tricyclic anti –depressants  and  
anti-convulsants given in low dosages can be useful in treating the burning mouth 
syndrome  however; these  should  be used  sparingly as they can be  addictive  (Vernillo, 
2003).Symptoms of burning mouth have been found in undiagnosed cases of Type 2 
diabetes, most of which have been resolved after medical diagnosis and subsequent 
treatment, directed at improving glycaemic control (Vernillo, 2003). 
 
2.10.4 Management of gingivitis 
 
Gingivitis may progress to periodontitis if it is not treated early enough. The rationale 
behind treatment of gingivitis is to eliminate the local irritants thereby reducing the 
inflammation of the gums. Plaque has to be removed through scaling and polishing 
because the components of microbial plaque have the potential to induce an initial 
infiltrate of inflammatory cells which may lead to connective tissue destruction (Vernillo, 
2003). The use of a mouthwash is recommended as an adjunct to treatment (see 2.10.5). 
Although there are many mouthwashes to choose from, the efficacy of chlorhexidine has 
been shown to be very good. This drug has been shown to be the most effective 
antiplaque and antigingivitis chemotherapeutic agent available (Wilkins, 1999). 
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2.10.5 Management of periodontitis 
 
Periodontal treatment is an essential requirement in a diabetic patient. In a meta-analysis 
of ten intervention studies, periodontal treatment resulted in a 0.66 percent reduction in 
absolute HbA1c levels among patients with diabetes (Wilder et al. 2009). 
 
The therapeutic goals in periodontal disease are to alter or eliminate the origin of the 
microbes and all contributing factors so as to prevent disease progression and to prevent 
recurrent periodontitis (Kim and Amar, 2006). Although periodontitis rarely causes death, 
it can lead to more serious oral infections such as fascial space infections and may be a 
major factor in bacteraemia (Bjelland et al. 2002).  
 
A conventional approach to management of periodontitis is preferable. Patients with 
diabetes should receive regular scaling so as to remove plaque and calculus deposits. 
Local debridement with 1% povidone-iodine should be done. Sound oral hygiene 
practices like brushing 3 times/day and flossing should be reinforced by the dental team. 
The use of antibiotics is recommended and the following drugs are often used: 
 
Amoxil 250mg three times/ day for 5 days for patients who are not allergic to penicillin  
Erythromycin 250mg three times/ day for 5 days for patients who are allergic to 
penicillin.  
Each of the above-mentioned drugs must be accompanied by any of the following: 
Metronidazole 200mg three times/ day for 5 days or Clindamycin 300mg three times/day 
for 5 days or Clavulanic acid and Amoxil 375mg three times/ day for  5 days. 
These drugs target a broad spectrum of bacteria which is why they are used for 
periodontitis management. 
 
Periodontal surgical procedures can be performed on patients with advanced periodontitis 
but not without reservations as surgery may potentiate unwanted complications. Often 
there is a need to modify the patient’s medication before and after surgery and there may 
be delayed wound healing since the patient is diabetic (Vernillo, 2003).  
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Surgical treatment of periodontitis involves removal of inflamed tissues to reduce the 
damage to the alveolar bone around the infected area and this has an added advantage 
since it enhances accessibility to areas where root planning and scaling could not be 
reached to remove plaque and calculus (Kim and Amar, 2006). 
 
With the causative bacteria eliminated either through scaling and local debridement or 
through surgical methods, healing can be anticipated in the bone and soft tissues. Since 
the surgical treatment poses more risk, a non-surgical approach is recommended in the 
form of debridement and tetracycline antibiotic therapy. Tetracycline is preferable 
because of its known association with improvement of glycaemic control (Vernillo, 
2003). This drug has also been reported as an inhibitor of human matrix 
metalloproteinases which are connective tissue degrading enzymes.  
 
The use of 0.2% Chlorhexidine gluconate mouthwash has beneficial effects because it is 
bactericidal. This drug is rapidly absorbed to teeth and pellicle and is released slowly, 
thus prolonging the bactericidal effect (Wilkins, 1999). Phenol compounds like Listerine 
may also be used because they are known to be effective in preventing the development 
of supragingival plaque and gingivitis (Wilkins, 1999). Oxygen compounds like 
Triclosan are mainly directed against strict anaerobes which cannot survive in the 
presence of oxygen and may be beneficial in management of periodontal disease 
(Wilkins, 1999). This drug is both bacteriostatic and bacteriocidal. Patients with 
periodontal disease should be recalled regularly to monitor progress and to assist the 
patient with professional removal of plaque and calculus where indicated. 
 
2.10.6 Management of dental caries 
 
Dental caries should be managed according to the size and depth of the lesion otherwise 
the caries will progress and eventually lead to tooth loss. It is important to remember the 
association of caries with salivary dysfunction and xerostomia since they may well be the 
contributing factors to dental caries in a diabetic patient.  
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Apart from dental fillings, topical treatments such as fluoride-containing mouthrinses and 
salivary substitutes may help prevent caries. Fluoride compounds, gels, aqueous solutions 
and dentrifices are all possible options in treatment of dental caries. Topical fluoride can 
be subdivided into fluorides applied by professionals or those that can be applied at 
home. From the professionally-applied fluorides, stannous fluoride has been found to be 
3 times more effective in inhibiting enamel dissolution by weak acids than sodium 
fluoride (Wilkins, 1999). Fluoride varnishes like Duraphat, Epoxylite and Elmex can be 
applied on patients by a professional. The use of fluoride-containing toothpaste for caries 
prevention at home should be encouraged. Sodium fluoride mouthrinses are also believed 
to be beneficial because of their fluid nature which allows the fluoride to reach areas 
which are inaccessible to the toothbrush (Wilkins, 1999).  Oral health care workers 
should also reinforce sound oral hygiene practices and dietary counselling to the patient 
so that the patient can brush, floss and choose less cariogenic foods, all of which will 
enhance caries prevention. 
 
2.10.7 Management of salivary dysfunction 
 
This condition should be managed because of its potential complications. Difficulty in 
lubricating, masticating tasting and swallowing are some of the complications resulting 
from this condition and may all contribute to impaired nutritional intake of the diabetic 
patient (Vernillo, 2003). As in xerostomia, saliva substitutes and stimulants can be used 
to treat saliva hypofunction. 
 
2.10.8 Management of altered taste sensation 
 
Since this condition has a strong correlation for Candida and xerostomia, a positive 
outcome may be achieved by treating the accompanying fungal infection. Improvements 
in altered taste sensation may occur when diabetes mellitus metabolic control is 
established or when xerostomia and associated candidiasis are controlled (Rees, 2000). 
 
 
 
 
 
 
 51
2.10.9 Management of acute oral infections 
 
These can be managed by achieving good glycaemic control in a diabetic patient as this 
will reduce the impact of acute oral infections. For those diabetic patients who might 
have recurrent Herpes Simplex Virus infection, agents such as oral acyclovir can be used 
for this infection both prophylactically and therapeutically (Vernillo, 2003). This drug is 
contraindicated for patients who are diabetic and have renal insufficiency as it can lead to 
nephrotoxicity (Vernillo, 2003) but it is safe to use on any other diabetic patient. Other 
drugs of choice are Valacyclovir 100mg three times / day or Famciclovir 250mg three 
times/ day for 7 days. 
 
For acute oral infections like periodontal abscesses antibiotics similar to the ones used for 
periodontitis management are used. A mouthwash like chlohexidine gluconate may also 
be used as an adjunct. 
 
 
2.11 Diabetic Emergencies in the dental surgery 
 
Dentists should be alert to hypoglycaemia, a condition that is highly dangerous as it may 
lead to the patient getting a seizure or even loosing consciousness (Kidambi and Patel, 
2008, Mealey, 2003). The classical signs and symptoms of this condition include 
sweating, tremors, confusion, agitation, anxiety, dizziness, tingling or numbness and 
tachycardia. If this condition is suspected it can be confirmed by taking a glucometer 
reading and the patient must be given 15g of glucose orally. In the event that a patient is 
unable to take this glucose orally, an intravenous line (IV) should be set up and 25-50ml 
of 50% dextrose solution should be administered (Kidambi and Patel, 2008; Mealey, 
2003).  A subcutaneous injection of 1mg of glucagon should be injected in case it is not 
possible to set up the IV line. After the treatment, the signs and symptoms of 
hypoglycaemia should resolve between 10-15 minutes. As a precaution, the patient must 
be observed for 30-60 minutes after recovery and the blood glucose levels can then be 
rechecked using the glucometer. 
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It is not uncommon for marked hyperglycaemia patients to present with the exact 
symptoms as described for hypoglycaemia. Again, the important step is to confirm the 
glucose level with a glucometer. However, should a glucometer not be available it is safer 
to treat this as hypoglycaemia because the extra dose of glucose given will not have a 
significant or detrimental effect on the hyperglycaemia, but  if the patient was not treated 
as hypoglycaemia, he could suffer life threatening outcomes (Mealey, 2003). 
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CHAPTER THREE: AIMS AND OBJECTIVES 
 
 
3.1 Aim:  To compare the oral health problems in diabetic and non-diabetic patients 
attending at Prince Mshiyeni Memorial Hospital, Durban, KwaZulu-Natal 
 
 
3.2 Objectives: 
• To compare the oral health status, oral problems and dietary habits of diabetic 
and non-diabetic patients attending Prince Mshiyeni Hospital.  
• To describe the oral health characteristics of the diabetic patients attending 
Prince Mshiyeni Hospital. 
• To determine the effect of diabetes on the self perceived quality of life.  
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CHAPTER FOUR: RESEARCH METHODOLOGY 
4.1 Introduction 
This chapter discusses the research design and methodology. It discusses the study 
population, study site, study design, data collection, selection of study population, sample 
size estimation, data analysis and ethical considerations. It also describes the research 
instrument as well as the data collection methods. 
 
4.2 Study design 
The study design was an analytic cross-sectional survey that was carried out in October 
2008 to December 2008 at Mshiyeni Memorial Hospital.  
 
4.3 Study site 
The study site was the Prince Mshiyeni Memorial Hospital (PMMH) in Umlazi, Durban. 
This is a 1200 bed facility regarded as a Regional Hospital, providing both district level 
services and specialist services for the most part of KwaZulu-Natal. 
 
4.4 Study population 
The study population was defined as all the diabetic and non-diabetic patients whose ages 
ranged between 25 and 75 years and who were attending PMMH from October 2008 to 
December 2008. The three months time frame for data collection was decided upon as 
this would have given the researcher more time to collect data, because the diabetic clinic 
opens once a week. The diabetic subjects recruited for this study were patients attending 
the diabetic clinic at Prince Mshiyeni Memorial Hospital. The non-diabetic subjects 
included those patients with a clear medical history of no diabetes and who attended the 
same hospital’s out-patients department for other reasons. The age range of 25-75 years 
was decided upon because it was perceived as appropriate since it would include both 
Type 1 and Type 2 patients since the study was planned to focus on these two types of 
diabetes. The decision on this age range was based on information obtained from the 
literature (Sandberg et al (2000), Ogunbodede et al (2005), Campus et al (2005) and other 
studies discussed in Taylor and Borgnakke (2008). 
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Inclusion criteria 
All patients who were dentate, with at least 6 teeth, presenting at the out patients 
department and the diabetic clinic, aged between 25 and 75 years of age 
 
Exclusion criteria  
All patients who were less than 25 and more than 75 years of age and patients who were 
edentulous. 
 
4.5  Selection of study participants 
A nonrandom convenience sampling was used in the selection of the study participation. 
Patients who fulfilled the inclusion criteria were recruited as they came for consultation at 
the hospital. The non-diabetic patients were recruited as they presented for medical 
consultation in the out-patients department during the study period. Patients who 
presented with their files to the diabetic clinic for collection of diabetes medication were 
included in the study as the diabetic patients. 
 
4.6 Sample size estimation 
The sample size calculations were based on the following assumptions: 
Type I error of 5% (two tailed), Type II error of 10%. 
Among the diabetic patients the prevalence of oral health problems was expected to be 
45% and the prevalence of oral health problems among non-diabetic patients was 
expected to be 25%. Therefore the required number of patients in each group was 150 
(two independent samples). The study consisted of 300 patients (150 diabetic and 150 
non-diabetic) who all attended PMMH during October-December 2008. 
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4.7 Measurements and data collection instruments 
A data capture sheet and administered questionnaires were used for data collection. The 
purpose of the questionnaire was to collect factual and/or attitudinal data for 
measurement. It was designed to obtain accurate and valid responses. 
 
Design rules 
The same rules of design apply to all types of questionnaire: 
• It must suit the aim of the study 
• It must suit the nature of the respondent 
• It should be clear, simple, unambiguous 
• The design should minimize potential errors from respondents and coders 
• The subject of the questionnaire should interest the respondent, encourage their co-
operation and elicit truthful answers 
• Well worded questions are essential, and pitfalls must be avoided, for example, 
‘double-barreled questions’ that is, when two questions are included in one- the 
questions will have to be separated so that the respondent and the researcher can 
distinguish between the two. 
• The wording of the questions should not lead the respondent to feel obliged to answer 
in a particular way, which may not be truthful 
• Questions must not alienate either the respondent or the researcher 
• Efficient and meaningful analysis of the acquired data should be possible. 
Instrument used 
Questionnaires and data capture sheets (Appendix I) with open and closed ended 
questions were the instruments used to collect the data. They were designed to ensure that 
it suited the aim and objectives of the study and were simple, clearly understood and 
unambiguous. 
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The development of the study questionnaire 
 
Planning of the questionnaire began in March 2008. It was developed following group 
discussions with patients with diabetes and health care professionals caring for them. 
After a thorough review of the literature, the questions were formulated. The data from 
the questionnaires was grouped into the following categories: Demographics, Oral health 
status, Oral problems and dietary habits, exercise habits and perceived quality of life. The 
diabetic cohort were asked about the duration of their disease, history of oral problems, 
medication taken and their perceived quality of life since being diagnosed with diabetes. 
Piloting the questionnaire 
 
In September 2008, the completed questionnaires were tested on six participants. The 
pilot study was carried out to: 
• Test the suitability of the method of collecting the data 
• Check the adequacy of the questionnaire 
• Check that all questions were clear and unambiguous 
• Remove any items that did not yield usable data. 
Preparation for the final draft 
 
After the pilot study, irrelevant and ambiguous questions for the interviews were 
identified and either reformulated or deleted. This resulted in a general improvement of 
the questionnaire and an increase in the efficiency of the enquiry. The final draft of the 
questionnaire (Appendix I) were then printed and copied for the larger study. The design 
and construction of the instrument took about 6 months to be completed. The 
questionnaire was piloted. Data was collected using a structured data capture sheet and 
questionnaire (Appendix I). The questionnaire was piloted (see Piloting the 
questionnaire, Section 4.7). The questionnaire was translated into IsiZulu.  Section A was 
for oral examination and section B for the interview.  
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4.8 Data collection 
 
Data was collected using a data capture sheet and a questionnaire by the principal 
investigator (qualified dentist) fluent in English and isiZulu. Firstly the purpose of the 
study was explained to the patients by the researcher. When the patients agreed to 
participate in the study they were asked to sign an informed consent form (Appendix II). 
The oral examination was performed by a qualified dentist (the researcher) to assess oral 
health status. The oral examination was performed with the use of a wooden spatula, 
dental mirror explorer probe and in daylight. The sequence of the examination was the 
teeth, gingiva, floor of the mouth, tongue, buccal mucosa and palate (see Section 4.9.3 for 
detailed description) and the information collected included DMFT, oral health status, 
gingival index and oral pathology lesions. Section A of the questionnaire was completed 
during the oral examination process. After the oral examination, the researcher 
interviewed the patients on their oral functions and section B of the questionnaire was 
completed. 
 
The information collected during the interview included oral function, history of oral 
problems, dietary habits, physical activities and self-perceived quality of life.  Any 
patient with oral health problems was referred to the oral health clinic at the same 
hospital for treatment and further management. 
 
4.9 Oral examination 
 
4.9.1 Plaque index (Pl I) 
The plaque index, based on the debris index of Greene & Vermillion (1964) was used to 
assess the coronal extension of plaque for the purpose of his study. A total of 6 teeth per 
patient was assessed. It was perceived as a precise and reliable index to measure oral 
cleanliness in this study. None of the study participants had the entire teeth covered by 
plaque. 
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Codes and criteria 
0  None (no debris or stain present) 
1=  soft debris covering not more than one third of the tooth surface being examined, or 
the presence of extrinsic stains without debris, regardless of surface area covered 
2= soft debris covering more than one third but not more than two thirds of the exposed 
tooth surface. 
3= Soft debris covering more than two thirds of the exposed tooth surface 
9= Not recorded 
 
4.9.2 Dentition status and treatment need – DMFT 
 
The decayed, missing and filled teeth index was used to determine dental caries 
experience, past and present. Third molars were not counted. A systematic approach to 
the assessment of the dentition status and treatment was adopted using the WHO 
Guidelines to Oral Health Surveys (1997).  
 
Codes and criteria 
0 Sound crown. A crown was recorded as sound if it showed no evidence of treated 
or untreated clinical caries. In addition, a crown with the following defects was also 
coded as sound: white or chalky spots, discoloured or rough spots that were not soft 
to touch with the metal explorer probe, stained pits or fissures in the enamel that did 
not have visual signs of undermined enamel, or softening of the floor or walls 
detectable with an explorer probe, dark, shiny, hard, pitted areas of enamel in a 
tooth showing signs of moderate to severe fluorosis, lesions that, on the basis of 
distribution or history, appeared to be due to abrasion. 
Sound root. A root was recorded as sound when it was exposed and showed no 
evidence of treated or untreated clinical caries. (Unexposed roots are coded as 8) 
 
1 Decayed crown. Caries were recorded as present when a lesion in a pit or fissure, 
or on a smooth tooth surface, had an unmistakable cavity, undermined enamel, or a 
detectable softened floor or wall. A tooth with a temporary filling, or one which is 
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sealed (code 6) but also decayed was also included in this category. The explorer 
probe was used to confirm visual evidence of caries on the occlusal, buccal and 
lingual surfaces. Where any doubt existed, caries was not recorded as being present. 
Decayed root. Caries was recorded as present when a lesion felt soft or leathery to 
probing with the explorer probe. If the root caries was discrete from the crown and 
required a separate treatment, it was recorded as root caries. For single carious 
lesions affecting both the crown and the root, the likely site of origin of the lesion 
was recorded as decayed. When it was not possible to judge the site of origin, both 
the crown and the root were recorded as decayed. 
2 Filled crown, with decay. A crown was considered filled, with decay, if it had one 
or more permanent restorations and one or more areas that were decayed. 
Filled root, with decay. A root was considered filled, with decay, if it had one or 
more permanent restorations and one or more areas that were decayed. For any 
restoration involving both the crown and the root with secondary caries, the most 
likely site of the primary lesion was recorded as filled, with decay. When it was not 
possible to judge the site of origin of the primary carious lesion, both the crown and 
the root were recorded as filled, with decay. 
 
3 Filled crown, no decay. A crown was considered filled, without decay, when one 
or more permanent restorations were present and there was no caries anywhere on 
the crown.  A tooth that had been crowned because of previous decay was recorded 
in this category. A tooth that had been crowned for other reasons (e.g. a bridge 
abutment), was coded as 7. 
Filled root, no decay. A root was considered filled, without decay, when one or 
more permanent restorations were present and there was no caries anywhere on the 
root. For any restoration involving both crown and root, the most likely site of the 
primary lesion was recorded as filled. 
 
4 Missing tooth, as a result of caries. This code was used for teeth that had been 
extracted because of caries and was recorded under coronal status. The root status 
of a tooth that had been scored as missing because of caries was coded as 7 or 9. 
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5 Tooth missing, for any other reason. This code was used for teeth judged to be 
absent congenitally, or extracted for orthodontic reasons, periodontal disease, 
trauma, etc. 
 
6 Fissure sealant. This code was used for teeth in which a fissure sealant had been 
placed on the occlusal surface. 
 
7 Bridge abutment, crown, veneer. This code was used under coronal status to 
indicate that a tooth formed part of a fixed bridge i.e. is a bridge abutment. It was 
also used for crowns placed for reasons other than for caries and for veneers or 
laminate covering the labial surface of a tooth on which there was no evidence of 
caries or a restoration. Missing teeth replaced by bridge pontics were coded 4 or 5 
under coronal status, while root status was scored 9. 
 
8 Unerupted crown. This code was used for a tooth space with an unerupted 
permanent tooth. Teeth scored as unerupted were excluded from all calculation 
concerning dental caries. This category does not include congenitally missing teeth, 
or teeth lost as a result of trauma, etc.  
 Trauma (fracture). A crown was scored as fractured when some of its surface was 
missing as a result of trauma and there was no evidence of caries. 
9 Not recorded. This code was used for any tooth that could not be examined for any 
reason. It was used under root status to indicate either that the tooth had been 
extracted or that calculus was present to such an extent that a root examination was 
not possible. 
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4.9.3 Oral mucosa examination procedure 
An examination of the oral mucosa and soft tissues in and around the mouth was made on 
every participant. Any abnormalities of the mucosa or of the gingiva were recorded on 
the chart on the data capture sheet (Roed-Petersen and Renstrup, 1969). In addition, a full 
description of the lesion’s size, shape, type and anatomical site was documented. The oral 
examination was thorough and systematic and was performed in the following sequence: 
 
(i) Labial mucosa and labial sulci (upper and lower) 
(ii) Labial part of the commisures and buccal mucosa (right and left) 
(iii) Tongue (dorsal and ventral surfaces, margins) 
(iv) Alveolar ridges/gingiva (upper and lower) 
(v) Floor of the mouth 
(vi) Hard and soft palate 
 
Two mouth mirrors or wooden spatulas were used to retract the tissues. The following 
procedure was used and the following codes were used to record the absence, presence or 
suspected presence of the condition: The lips were examined with the mouth closed and 
open. The colour, texture and any surface abnormalities of the vermillion border were 
noted. The mandible vestibule was examined visually with the mouth partially opened. 
The colour and any swelling of the vestibular mucosa were observed. The maxillary 
vestibule and fraenulum with the mouth partially opened was examined. Using the plane 
mouth mirrors as retractors and the mouth wide open, the entire buccal mucosa extending 
from the commisures and back to the anterior tonsillar pillar was examined. Any changes 
in pigmentation, colour, texture and mobility of the mucosa were noted. Alveolar ridges 
were examined from all sides (bucally, palatally, lingually). 
 
With the tongue at rest and the mouth partially opened the dorsum of the tongue was 
inspected for any swelling, ulceration, coating or variation in colour or texture. The 
patient was then asked to protrude the tongue and the examiner noted any abnormality of 
mobility. The margins of the tongue were inspected with the aid of the mouth mirrors and 
then the ventral surface was observed.  
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While the tongue was still elevated, the floor of the mouth was inspected for swellings or 
any other abnormalities. With the mouth wide open and the subject’s head tilted 
backwards, the base of the tongue was gently depressed. The hard palate was inspected 
first followed by the soft palate. Any mucosal or facial tissues that seemed to be 
abnormal, as well as the submandibular and cervical lymph nodes, were palpated. 
 
4.9.4 Appearance of marginal gingiva (adapted from Löe & Silness, 1963) with an 
addition of criteria 3 
 
The appearance of the marginal gingiva by Silness and Löe (1964) was adapted for use as 
the gingival index to assess the gingival area using the following code: 
 
Code and criteria: 
0 = normal gingiva 
1 = mild marginal gingivitis, slight colour change & oedema 
2 = moderate gingival inflammation, redness & glazing 
3 = a distinct red band along the marginal gingiva from papilla to papilla 
4 = severe inflammation, marked redness & oedema, with ulceration or spontaneous 
bleeding. 
 
4.9.5 Criteria for interview questions and self-reported responses 
 
The periodontal status was assessed by checking for obvious tooth mobility, loss of 
attachment and gingival recession and recording these during charting. The presence of 
any of these was regarded as evidence for periodontal disease and was documented on the 
data capture sheet. Pocket depths were not measured. 
 
Sensitivity to the teeth was defined as any tooth that was sensitive to cold air or cold 
water at the time of the examination. This was verified by blowing some air from the air 
syringe and squirting some cold water and observing the response from the patient. 
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Gum problems were defined by any of the following: 
1. Bleeding gums when eating or brushing 
2. Swollen gums 
3. Painful gums 
4. Spontaneous bleeding of the gums 
 
Poor wound healing was evaluated by asking the following questions: 
1. How long does it take for your wound to heal if you have an injury? 
2. Do you think that your wounds heal fast if you have been injured? 
3. How long did it take before your socket healed when you last extracted a tooth? 
A response of two weeks or more, coupled with the patients perception of poor wound 
healing was classified as poor wound healing. 
 
Xerostomia was assessed by asking the subjects the following questions: 
1. Does your mouth constantly feel dry? 
2. Do you ever have difficulties swallowing foods if you don’t drink water as you eat? 
3. When eating your meal does your mouth often feel dry? 
Subjects who responded positively for 2 or more of these questions coupled with a 
positive intraoral examination for dryness were classified as having xerostomia. 
 
Halitosis was regarded a problem only if the patient thought they have a bad breath and if 
more than one person has complained about their bad breath. This was assessed by 
smelling the patient’s exhaled air as well as the oral cavity for verification by the 
researcher. 
 
Healthy Eating was assessed by asking the following questions: 
1. How many meals do you eat in one day? 
2. How often do you eat “take-aways” in one week? 
3. When preparing your meal  you 
a. fry with cooking oil. 
b. boil with little or no salt 
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c. grill with olive oil 
d. Remove obvious fat tissue or chicken skin before boiling. 
4. Which one of these food groups does your daily meal contain? 
 a. protein 
 b. fat 
 c. carbohydrate 
 d. vegetables 
Subjects who consumed 3 meals or more and ate a balanced diet, with an effort to limit 
oil were regarded as healthy eaters. 
 
To evaluate how life changed after a diagnosis of diabetes subjects were asked to speak 
about those symptoms which they experienced only after being diagnosed with diabetes. 
These symptoms were then grouped as neuropathy, nephropathy, cardiovascular, perioral, 
peripheral vascular disease or retinopathy according to signs and symptoms.  
 
4.9.6 Treatment guidelines for patients 
 
Treatment requirements will be assessed for the whole tooth, including both coronal and 
root caries. Immediately after the status of a tooth is recorded, and before proceeding to 
the next tooth, the type of treatment required, if any, will be recorded. If no treatment is 
required, code 0 will be assigned next to the tooth. The codes and criteria for treatment 
needs will be as follows: 
0=  No treatment .This code applies to a crown and a root which are both sound and 
 therefore should not receive any treatment. 
P= Preventive, caries arresting care 
F= Fissure sealant 
1= One surface filling 
2= Two or more surface filling 
 Code P, F, 1 or 2 will be used to indicate treatment required to: 
 ● Treat initial, primary or secondary caries 
 ● Treat discolouration of a tooth, or a developmental effect 
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 ● Treat lesions due to trauma, abrasion, erosion or attrition 
 ● Replace unsatisfactory fillings or sealants 
 
A sealant will be considered unsatisfactory if partial loss has extended to exposure of a 
fissure, pit or junction or surface of the dentine which requires resealing. 
A filling will be considered unsatisfactory of one or more of the following conditions 
exist: 
 ● a deficient margin to an existing restoration that has leaked or is likely to permit 
leakage into the dentine 
 ● an overhanging margin of an existing restoration that is causing obvious local 
 irritation to the gingival and cannot be removed by recontouring of the 
 restoration. 
 ● a fracture of an existing restoration that either causes it to be loose or permits 
leakage into the dentine 
 ● discolouration 
3 Crown for any reason 
4 Veneer or laminate 
5 Pulp care and restoration. This code will be used to indicate that a tooth probably 
needs pulp care prior to restoration with a filling or crown because of deep 
extensive caries or because of trauma. 
6 Extraction. A tooth will be recorded as indicated for extraction when caries has 
destroyed the tooth and it cannot be restored 
Periodontal disease has progressed so far that the tooth is loose, painful or 
functionless, and cannot be restored to a functional state. 
A tooth needs to be extracted for a prosthesis 
Extraction is required for cosmetic reasons or because of impaction 
7 Fillings. A tooth will be recorded as indicated for a filling when: 
 ● Evidence of caries exists on the crown or root and no pulpal involvement is 
suspected. 
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8 Patients were referred for scaling and polishing where gross calculus deposits, tooth 
mobility   and dental plaques have been identified 
 ● Where there’s evidence of inflammation of the gingival due to the presence of 
bacterial plaque or calculus. 
9. Oral pathology. This code will be given to all patients presenting with oral 
pathology lesions and such patients will be referred for further investigations. 
 
4.10 Intra-examiner calibration 
 
For the oral examination there was only one examiner. Consistency was determined by 
examining a randomly selected group of 10 patients twice, on successive days. These 
patients possessed, collectively, the full range of conditions expected to be assessed in the 
study. By comparing the results of the two examinations, the examiner was able to obtain 
an estimate of the extent and nature of the diagnostic errors. If the level of agreement 
between the examinations did not meet the recommended minimum level, the examiner 
reviewed the interpretation criteria and additional calibration examinations were 
conducted until an acceptable consistency was achieved. Agreements were in the range of 
85-90%. 
 
4.11 Data analysis 
 
The demographic and DMFT characteristics of the study participants were summarized 
for both groups. Some of the characteristics considered were age, gender, race, plaque 
index, number of teeth decayed, number of teeth missing and number of teeth filled. 
Continuous variables were presented using the following summary statistics, number of 
patients (n) mean, standard deviation (sd), minimum (min) median and maximum (max). 
 
Categorical variables were presented using frequencies and percentages for each response 
category were given for diabetic and non-diabetic patients. Continuous variables were 
compared using t-tests, whereas categorical variables were compared using chi-squared 
test or Fisher’s exact test.  
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The level of significance used for the comparisons in this study was 5%. Logistic 
regression techniques were used to examine the effect of diabetes on self perceived 
quality of life controlling for age, gender, healthy eating plan and exercising activities. 
The magnitude of the risk was assed using odds ratios (OR). The percentages of diabetic 
and non-diabetic were compared by calculating a point estimate (OR) and 95% 
confidence interval for the risk difference. 
 
4.12 Validity and reliability 
 
The principal investigator (fluent in English and isiZulu) was the only investigator 
involved in conducting interviews, keeping records, gathering and interpretation of data, 
thereby assuring confidentiality and the standardized recording of information. 
 
4.13 Ethical considerations 
 
The study was approved by the Ethics Committee at Prince Mshiyeni Memorial Hospital 
as well as the Provincial Health Research Committee at the Health Research and 
Knowledge Management sub-component for KwaZulu-Natal Department of Health and 
the Senate Research Committee, University of the Western Cape. The participants in the 
study were required to complete a consent form (Appendix II) if they were willing to 
participate in the study. Participation was voluntary and each individual had the right to 
refuse to be included in the study or to withdraw from the study at any time. Furthermore, 
it was re-iterated that their decision to participate or not, will not affect their management 
or care in any way whatsoever. The participants were assured of confidentiality regarding 
the information they provide should they decide to take part. The CPITN attachment loss 
and mobility indices were not performed in this study due to lack of resources. However, 
all the patients with a recession and tooth mobility were referred to the dental clinic at the 
same hospital. 
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CHAPTER FIVE: RESULTS 
 
The study findings are discussed in this chapter. Demographic information is presented 
followed by a comparison of oral health status between diabetic and non-diabetic 
patients, comparison of oral problems and dietary habits between the disease status 
categories, a description of diabetic-specific oral health characteristics and finally the 
impact of diabetes on the self perceived quality of life.  
 
5.1 Demographic information 
 
Table 2 shows the demographic information of the study participants by diabetic diseases 
status. The study consisted of 300 patients (150 diabetic and 150 non-diabetic). Most 
study participants (90%) were black African and nearly 77% of the participants in each 
group were females. The gender distribution was similar for diabetic and non-diabetic 
groups (p=0.891). The age ranged from 32 to 74 years and 25 to 75 years for diabetic and 
non-diabetic patients respectively. The difference in average age was statistically 
significant (p<0.0001) with the average amongst non-diabetics being younger than the 
diabetic group. 
Table 2 
Demographic information by diabetic disease status 
 
  Disease status  
  Diabetic (n=150) Non-diabetic(n=150) p-value 
Variable Category Freq % Freq %  
Gender      0.891 
 Male 34 22.67 35 23.33  
 Female 116 77.33 115 76.67  
Race      0.562 
 African 148 98.67 149 99.33  
 Indian 2 1.33 1 0.67  
Age        
 Mean± S.D  55.3±8.5  42.3±3.2 <0.0001 
 Min  32  25  
 Q1  49  31  
 Q3  61  51  
 Median  55  41.5  
 Max  74  75  
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Table 3 shows the plaque index between diabetic and non-diabetic patients. There was a 
statistically significant association between plaque index and diabetic status (p<0.0001). 
A higher percentage of diabetic patients had a plaque index of greater than 1/3 compared 
to non-diabetic patients (61% vs. 23%)  
 
Table 3 
Plaque index by diabetic disease status 
 
  Disease status  
  Diabetic (n=150) Non-diabetic(n=150) p-value 
Variable Category Freq % Freq %  
Plaque Index      <0.0001 
 None 7 4.67 44 29.33  
 <1/3 51 34.00 71 47.33  
 >1/3 92 61.33 35 23.33  
 Max  74  75  
       
 
The total number of decayed, missing or filled teeth among diabetic and non-diabetic 
patients is presented in Table 4. The mean DMFT was higher for diabetic patients 
compared to non-diabetic patients (7.2 vs 5.4) with a median of 6 for diabetic patients and 
4.5 for non-diabetic patients. The difference in the DMFT was statistically significant (p= 
0.0019). On average, the number of teeth missing was 5.5 for diabetic patients and 3.2 for 
non-diabetic patients and this was statistically significant. 
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Table 4 
The number of teeth decayed, filled or missing by diabetic diseases status (DMFT) 
 
Variable Statistic 
Diabetic 
(n=150) 
Non-diabetic 
(n=150) p-value 
Total number of teeth with problems 
(DMFT) Mean± sd 7.2± 5.5 5.4±4.2 0.0019 
 Min 0.0 0.0  
 Q1 3.0 2.0  
 Q3 10.0 7.0  
 Median 6.0 4.5  
 Max 21.0 20.0  
Number of teeth decayed     
 Mean± sd 1.4± 1.7 1.4±1.6 0.9458 
 Min 0.0 0.0  
 Q1 0.0 0.0  
 Q3 3.0 2.0  
 Median 1.0 1.0  
 Max 11.0 8.0  
Number of teeth missing     
 Mean± sd 5.5±5.1 3.2±3.2 <0.0001 
 Min 0.0 0.0  
 Q1 1.0 1.0  
 Q3 8.0 5.0  
 Median 4.0 2.0  
 Max 20.0 16.0  
Number of teeth filled     
 Mean± sd 0.2±0.7 0.8±1.7 <0.0001 
 Min 0.0 0.0  
 Q1 0.0 0.0  
 Q3 0.0 1.0  
 Median 0.0 0.0  
 Max 6.0 9.0  
Note: These figures were rounded off to one decimal place. 
 
5.2 Oral Health Status 
 
Figure 2 shows a comparison of the appearance of marginal gingiva between diabetic and 
non-diabetic patients. More than half (54%) of the diabetic patients had a moderate 
gingival index compared to 23% of the non-diabetic patients. The majority of non-
diabetic patients were in the mild category (39.3%). The distinct red band and severe 
categories (both an indication of severe inflammation of the marginal gingiva for this 
study) were more prevalent in the diabetic patients compared to non-diabetic patients 
(19.3% vs. 6.7%) and (3.3% vs. 0.7%) respectively. 
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Figure 2: Comparison of the appearance of marginal gingiva between diabetic and non-
diabetic patients 
 
 
Figure 3 depicts a comparison of reported oral lesions between diabetic and non-diabetic 
patients. A total of 182 oral lesions were observed among diabetic patients and 151 
among the non-diabetic patients (Appendix III). The number of oral pathology lesions 
was expressed as a percentage of 150 patients and these are compared in Figure 3. The 
oral lesions commonly observed among the diabetic patients compared to non-diabetic 
patients were candida (41.3% vs 8.0%), dental abscess (16.0% vs 2.7%), and ulcers 
(14.0% vs 2.0%). Nearly 90% of non-diabetic patients did not have any lesion compared 
to 43% of the diabetic patients. Some patients presented with more than one lesion. 
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Figure 3: Comparison of oral lesions between diabetic and non-diabetic patients 
 
A comparison of oral problems experienced between diabetic and non-diabetic patients is 
shown in Figure 4. A total of 328 oral lesions were observed among diabetic patients and 
190 among the non-diabetic patients (Appendix III). The number of problems within the 
oral cavity was expressed as a percentage of 150 patients and these are compared in 
Figure 4. The most prevalent oral cavity problems were periodontal disease (measured by 
recession and mobility during oral examination/charting) and xerostomia among the 
diabetic patients. Tooth decay was more common among the non-diabetic patients. 
Periodontal problems as well as xerostomia were reported by more than half of the 
diabetic patients, as oral cavity problems, followed by tooth decay (49.3%). In 58% of the 
150 non-diabetic patients tooth decay was the main oral cavity problem followed by 
periodontal disease (14.7%). 
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Figure 4: Comparison of oral cavity problems between diabetic and non-diabetic patients 
 
Table 5 shows a comparison of the frequency of oral function problems between diabetic 
and non-diabetic patients. There was a statistically significant association between pain in 
mouth and diabetic status (p=0.004). A higher percentage of diabetic patients often 
reported having pain in the mouth “often” compared to non-diabetic patients (22.0% vs 
11.3%) with one third having pain “sometimes” among diabetics compared to nearly one 
quarter of the non-diabetic patients. 
 
Teeth problems were experienced “sometimes” by nearly 41% of the diabetic patients 
compared to nearly 29% of the non-diabetic patients. The purpose of this question was to 
assist the researcher in case of any teeth-related problems that may have been missed 
during the intra-oral examination. Teeth problems were defined as caries, mobility, 
sensitivity or toothache. Where possible the responses were verified by the researcher 
using a probe or air syringe.  
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The percentage that reported experiencing teeth problems “often” were almost similar 
between the two groups (19% vs 18%). The association between the frequency of 
experiencing teeth problems and diabetic status is not statistically significant (p=0.053). 
There was a statistically significant association (p<0.001) between the frequency of gum 
problems and the diabetes status. Problems of the gums were defined as gums that were 
swollen, bleeding when brushing, painful, spontaneous bleeding, hyperplastic or 
suppurated and the responses were checked against the clinical presentation. Gum 
problems were experienced more “often” by diabetic patients compared to non-diabetic 
(18.7% vs 4.7%). A quarter (34%) of diabetic patients “sometimes” experienced gum 
problems compared to nearly 21% of the non-diabetic patients. 
Table 5 
Comparison of oral function by diabetes status 
 
Variable  Diabetic (n=150) Non-diabetic (n=150)  
 Categories Freq % Freq % p-value 
Pain in mouth 
     
 
0.004 
 Never 67 44.67 94 62.67  
 Sometimes 50 33.33 39 26.00  
 Often 33 22.00 17 11.33  
Problems with 
teeth      
 
0.053 
 Never 58 38.93 80 53.33  
 Sometimes 61 40.94 43 28.67  
 Often 29 19.46 27 18.00  
Do you have 
problems with 
gums      <0.0001 
 Never 71 47.33 112 74.67  
 Sometimes 51 34.00 31 20.67  
 Often have 28 18.67 7 4.67  
 
 
5.3  Oral problems and dietary habits 
 
Figure 5 shows a comparison of the problems associated with the teeth between diabetic 
and non-diabetic patients. A total of 177 oral problems were reported (and verified by the 
researcher) among diabetic patients and 174 among the non-diabetic patients (Appendix 
III).  
 
 
 
 
 76
Problems of caries, sensitivity, toothache and mobility were verified by the researcher. 
The number of oral problem citations was expressed as a percentage of 150 patients and 
these are compared in Figure 5. The teeth problem reported most was caries where 34% 
was reported by diabetic patients and 28% by non-diabetic patients. Toothache was 
reported by 21.3% and 23.3% of diabetic and non-diabetic patients respectively. 
Sensitivity (whether due to caries, abrasion or recession) was reported by 12.0% of 
diabetic and 9.3% of non-diabetic patients. Mobile teeth (measured by applying two blunt 
ends of metal  instruments for horizontal mobility and applying one blunt end on the 
occlusal or incisal edge for vertical mobility) were more common among diabetic patients 
compared to non-diabetic patients (11.3% vs 2.0%). 
34.0
28.0
11.3
2.0
21.3
23.3
12.0
9.3
39.3
53.3
0.0
10.0
20.0
30.0
40.0
50.0
60.0
Pe
rc
en
t (
%
)
Caries Mobile Toothache Sensitivity No preblem
Type of teeth problems
Comparison of self reported type of teeth problems between diabetic and 
nondiabetic patients
Diabetic
Nondiabetic
 
Figure 5:  A comparison of the self reported type of teeth problems between Diabetic and  
 
Non-diabetic patients. 
A comparison of gum problems ( defined as bleeding gums, swollen gums, painful gums 
without any inflammation or gums with spontaneous bleeding) between diabetic and non-
diabetic patients is presented in Figure 6. A total of 161 gum problems were reported 
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among diabetic patients and 158 among the non-diabetic patients (Appendix III) since 
some patients reported having more than one problem. The reported number was 
expressed as a percentage of 150 patients and these are compared in Figure 6. The most 
common gum problem reported was bleeding with 38.7% by diabetic patients and 22.0% 
by non-diabetic patients, followed by swollen gums (8.7% and 2.0%). Painful gums were 
reported by 6.7% of diabetic and 5.3% of non-diabetic patients. Spontaneous bleeding 
was more common among diabetic patients compared to non-diabetic patients (6.0% vs 
1.3%). 
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Figure 6: A comparison of self-reported gum problems between diabetic and non-diabetic 
patients. 
 
Table 6 displays a comparison of dietary characteristics between diabetic and non-
diabetic.  Healthy eating was defined as the following: Subjects who consumed 3 meals 
or more per day and ate a balanced diet, with an effort to limit the amount of oil (See 
Section 4.8.5). There was a statistically significant association between a reported healthy 
eating plan and diabetes status (p<0.0001).  
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A higher proportion of diabetic patients followed a healthy eating plan compared to non-
diabetic patients (76.7% vs 35.3%). Nearly one third of the diabetic patients began a 
healthy eating plan more than ten years ago compared to 6% of the non-diabetic patients. 
This difference was statistically significant (p<0.0001).   
 
Table 6 
  
A comparison of dietary characteristics between Diabetic and Non-diabetic 
 
  Diabetic Non-diabetic  
  Freq % Freq % pvalue 
Do you follow a healthy eating 
plan?      <0.0001 
 No 35 23.33 97 64.67  
 Yes 115 76.67 53 35.33  
When did you start following a 
healthy eating plan?      <0.0001 
 Never 33 22.00 91 60.67  
 0 to 4 years 32 21.33 35 23.33  
 5 to 9 years 36 24.00 15 10.00  
 >10 years 49 32.67 9 6.00  
Is it beneficial to eat healthy 
when diabetic?      0.149 
 No 2 1.33 0 0.00  
 Yes 147 98.00 146 97.33  
 Unsure 1 0.67 4 2.67  
 
 
5.4 Exercising characteristics and perceived quality of life 
 
Exercising characteristics among diabetic and non-diabetic patients are shown in Table 7. 
There was a statistically significant association between following an exercising routine 
and diabetic status (p=0.015).  A higher proportion of diabetic patients reported following 
an exercising routine compared to non-diabetic patients (55.3% vs 38.7%). The frequency 
of exercise during the previous month was not statistically significantly associated with 
diabetic status (p=0.086). A higher proportion of diabetic patients exercised more (for 
one day or more) during the previous month compared to non-diabetic patients (58.7% vs 
45.7%). There was a statistically significant association between “reason for exercise” 
and diabetic status (p=0.021).  
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Almost two thirds of diabetic patients reported that they exercised because they wanted to 
be healthy and fit compared to 43% of non-diabetic patients. There was a statistically 
significant association (p<0.0001) between perceived quality of life and diabetic status. 
Only a quarter of diabetic patients perceived themselves as ‘very satisfied’ or “somewhat 
satisfied” with their quality of life compared to nearly 95% of non-diabetic patients. The 
majority of diabetic patients (86%) were “not satisfied” with their perceived quality of 
life. The reasons cited for this were those of medical complications associated with being 
diabetic. 
Table 7 
A comparison of exercising characteristics and perceived quality of life between Diabetic 
and Non-diabetic patients 
 
  Diabetic Non-diabetic  
  Freq % Freq % p-value 
Do you follow any 
exercising routine?      0.015 
 No 61 40.67 83 55.33  
 Yes 83 55.33 58 38.67  
 Sometimes 6 4.00 9 6.00  
How many times did you 
exercise last month?      0.086 
 None 62 41.33 81 54.00  
 1 to 10 days 13 8.67 7 4.67  
 10 to 20 days 15 10.00 17 11.33  
 20 to 30 days 60 40.00 45 30.00  
Reason for exercising      0.021 
 Don't exercise 59 39.33 82 54.67  
 Health and fitness 88 58.67 64 42.67  
 Weight loss 3 2.00 4 2.67  
Is it important to exercise 
when diabetic?      0.002 
 No 4 2.67 0 0.00  
 Yes 146 97.33 142 94.67  
 Unsure 0 0.00 8 5.33  
Perceived quality of life      <0.0001 
 Very satisfied 6 4.00 131 87.33  
 Somewhat satisfied 31 20.67 12 8.00  
 Not satisfied 113 75.33 7 4.67  
Reasons for perceived 
quality of life (QOL)    
  <0.0001 
 
Accepted my diabetes 
status 18 12.00 
 
0 
 
0.00 
 
 Diabetes complications 129 86.00 
 
0 
 
0.00 
 
 Other 3 2.00 
 
150 
 
100.00 
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5.5 Description of oral health characteristics among diabetic patients 
 
This section reported on the diabetic patient sample. Table 8 presents the results of their 
oral health characteristics. These patients experienced problems with their sense of taste 
with a quarter experiencing the problem “sometimes” and 3% experiencing the problem 
“often”. Nearly 80.5% of the 41 patients who indicated having sense of taste problems 
experienced a bitter taste. Almost all (97%) of diabetic patients indicated that being 
diabetic had changed their life. A third (35%) indicated that their life changed because 
they had developed 3 or more diabetes complications while 44% indicated that their life 
had changed because they had developed 2 or more complications. 
 
 
Table 8 
Oral health among Diabetic patients only 
 
  Frequency Percent 
Altered sense of taste    
 Never 109 72.67 
 Sometimes 37 24.67 
 Often 4 2.67 
Type of sense of taste (n=41)    
 Bitter taste 33 80.49 
 Certain foods funny 6 14.63 
 Not applicable 2 4.88 
History of oral problems    
 Before diabetes 16 10.67 
 After diabetes 129 86.00 
 Not applicable 5 3.33 
Has being diabetic changed your 
life in anyway?    
 Yes 146 97.33 
 No 4 2.67 
How did your life change after 
becoming diabetic?    
 3 or more complications 53 35.33 
 2 complications 66 44.00 
 1 complication 26 17.33 
 No complications 5 3.33 
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5.6 Length of time diagnosed with diabetes. 
 
The length of time since the diagnosis of diabetes is shown in Figure 7. Most of the 
diabetic patients had been diagnosed with diabetes for more than 5 years while 22% had 
been diagnosed for a period of 3 to 5 years. 
Period diagnosed with diabetes
46.67%
18.67%
12.67%
22.00%
1 to 2 years
3 to 5 years
6 to 10 years
>10 years
 
Figure 7: The length of time diagnosed with diabetes 
 
The type of the diabetes medication taken by the participants is shown in Figure 8. Three 
quarter of the diabetic patients were taking oral hypoglycemic medication alone, 17% 
were taking a combination of insulin and oral hypoglycemics and only 8% were taking 
insulin alone. 
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Type of diabetes medication used
74.67%
17.33% 8.00%
Insulin
Oral hypoglycemic
Combination
 
Figure 8: Type of diabetes medication taken by the diabetic participants 
 
5.7  Self perceived quality of life of the entire study sample 
This section reports on the factors that influence self perceived quality of life among all 
the study participants. Self perceived quality of life (PQOL) was measured using a 
question “How do your perceive your quality of life?” with responses “Very satisfied=3”  
“Somewhat satisfied=2” and “Not satisfied=1”. To explore the effect of diabetes on the 
probability of being “Very satisfied” with QOL and “Not satisfied” with QOL adjusting 
for age and gender, a multinomial logistic regression model was used with the reference 
group being “Somewhat satisfied”.  
 
Table 9 shows the factors included in the model and the reference group, the odds ratio 
(OR) and their corresponding 95% confidence intervals (CI) and p-value. Diabetic 
patients were statistically significantly less likely to perceive their quality of life as very 
satisfied after adjusting for age and gender (OR=0.0188; CI: 0.0059-0.0594). 
Furthermore, diabetic patients were almost six times more likely to perceive their life as 
not satisfied compared to non-diabetic. This perception was statistically significant 
(2.0073- 17.8047).  
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Table 9 
Multinomial logistic regression model of the impact of diabetic on PQOL adjusting for age 
and gender 
 
 
PQOL OR 
Wald statistic 
 p-value 95% CI for OR 
Ref: Somewhat satisfied Very satisfied    
Ref: Non-diabetic Diabetic 0.0188 0.000 0.0059- 0.0594 
 Age 0.9867 0.488 0.9502- 1.0247 
Ref: Male Female 0.5892 0.355 0.1920- 1.8082 
     
Ref: Somewhat satisfied Not satisfied    
Ref: Non-diabetic Diabetic 5.9782 0.001 2.0073-17.8047 
 Age 1.0134 0.501 0.9748-  1.0536 
Ref: Male Female 2.0510 0.093 0.8864-  4.7458 
Log likelihood value -166.29095  
 
 
Table 10 shows the results of the multinomial model adjusting for other confounding 
factors: a healthy eating plan and exercising. It presents factors included in the model and 
the reference group, the odds ratio (OR) and their corresponding 95% confidence 
intervals (CI) and p-value. Diabetic patients were again statistically significantly less 
likely to perceive their quality of life as very satisfied (OR=0.0245; CI: 0.0071-0.0843). 
 
The inclusion of healthy eating plan and exercising changed the magnitude of the effect 
of being diabetic: diabetic patients were now almost 10 times more likely to perceive 
their life as not satisfied compared to non-diabetic. This perception was statistically 
significant (2.7368- 33.3969). After adjusting for the other factors in the model, it was 
found that patients who do not exercise were significantly less likely to perceive their 
quality of life as being not satisfied compared to those patients who exercise. 
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Table 10 
The result of a multinomial logistic regression model of the impact of diabetic on PQOL 
adjusting for age, gender, exercise and healthy eating plan  
 
 PQOL (n=300) 
Odds 
Ratio   
Wald  
Statistic 
  p-value   95% Cl for OR 
     
Ref: Somewhat satisfied Very satisfied    
Ref: Non-diabetic Diabetic 0.0245 0.000 0.0071- 0.0843 
Ref: No Healthy eating plan-Yes 0.4303 0.122 0.1477- 1.2531 
Ref: Male Female 0.6183 0.409 0.1977- 1.9337 
 Age 0.9874 0.522 0.9497- 1.0265 
Ref: Yes exercise No Exercise 0.8712 0.791 0.3146- 2.4129 
 Somewhat exercise 0.3801 0.262 0.0702- 2.0587 
     
Ref: Somewhat satisfied Not satisfied    
Ref: Non-diabetic Diabetic 9.5603 0.000 2.7368-33.3969 
Ref: No Healthy eating plan-Yes 0.2212 0.005 0.0764-  0.6401 
Ref: Male Female 2.3711 0.053 0.9884-  5.6881 
 Age 1.0208 0.312 0.9808-  1.0624 
Ref: Yes exercise No Exercise 0.3627 0.017 0.1572-  0.8368 
 Somewhat exercise 0.3474 0.200 0.0690-  1.7489 
Log likelihood value -159.27419  
 
 
A logistic regression model was then used to determine the impact of diabetes on PQOL 
after combining “very satisfied” and “somewhat satisfied” responses into one group 
called “satisfied”. This resulted in a dichotomous outcome variable PQOL with only two 
responses, “satisfied” and “not satisfied”. 
 
Table 11 shows the factors included in the logit model and the reference group, the odds 
ratio (OR) and their corresponding 95% confidence intervals (CI) and p-value.  The effect 
of diabetes on PQOL drastically increased compared to the effect of the multinomial 
logistic regression. Diabetic patients were now almost 91 times more likely to perceive 
their quality of life as being “not satisfied” compared to non-diabetic patients. However 
this estimate lacked significance due to the large confidence intervals. 
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Table 11 
Logistic regression model of the impact of diabetic on PQOL adjusting for age, gender, 
exercise and healthy eating plan  
 
Ref: Satisfied Not satisfied 
Odds  
Ratio 
   Wald  
Statistic 
  P-value     95% CI for OR 
Ref: Non-diabetic  Diabetic 90.5158 0.000 29.8594- 274.3896 
Ref: No plan Healthy eating plan   0.30338 0.015 0.11559 -  0.7963 
Ref: Male Female   2.65718 0.017 1.1898   -  5.9345 
 Age  1.02551 0.170 0.9893   -   1.0631 
Ref: Yes Exercise No Exercise  0.38359 0.014 0.1790   -   0.8218 
 Sometimes exercise  0.45849 0.355  0.08790 -  2.3916 
Log likelihood -104.38441  
 
 
5.8 Summary 
 
The results of the present study indicated that there are statistically significant differences 
in oral health problems in diabetics. Diabetic patients displayed a higher prevalence of 
oral pathology lesions, poor oral hygiene status as well as a higher gingival index. There 
amount of decayed teeth in the diabetic patients were no different from the diabetic 
group. The average DMFT was significantly higher in the diabetic group compared to the 
non diabetic group. A higher proportion of diabetic patients indicated that they were 
following a healthy eating plan and had been diagnosed with diabetes for a period longer 
than five years. Nearly 75% of diabetic patients used oral hypoglycemic drugs to control 
the disease. Most diabetic patients were not satisfied with their quality of life when 
compared to non-diabetic patients. 
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CHAPTER 6: DISCUSSION AND CONCLUSION 
 
The aim of the present study was to compare the oral health problems in a sample of 150 
diabetic and 150 non-diabetic patients attending at Prince Mshiyeni Memorial Hospital, 
Durban, KwaZulu-Natal. In this study, diabetic patients exhibited poorer oral health when 
compared to their non-diabetic counterparts. Diabetic patients presented with more oral 
lesions, as is expected, due to the attenuated immunity caused by diabetes. 
 
Almost all of the participants were black. This was because the study setting mainly 
offers services in a predominantly black community. The study indicated that oral health 
problems were more common among the middle-aged people. The study findings 
consistently revealed that oral health problems were more prevalent among diabetic 
patients compared to non-diabetic patients. 
 
Nearly two thirds of diabetic patients had a Plaque Index greater than one third.  These 
results are similar to Sandberg et al (2000) where 2 diabetics were compared to non-
diabetics and the results showed that the diabetic patients exhibited more surfaces with 
bacterial plaque than non-diabetic patients, after using the Plaque Control Record method 
of measuring plaque (Sandberg et al. 2000). 
 
The mean DMFT was statistically different between the two groups and this concurs with 
Zielinski et al (2002) where the mean vales of DMFT were higher in the diabetic group 
compared to the non-diabetic group. In the present study, diabetic patients had a 
significantly higher average number of missing teeth compared with non-diabetic ones, 
unlike Zielinski et al (2002) who reported that the mean number of missing teeth was 
slightly higher among the non-diabetic group, although not statistically significant 
(Zielinski et al. 2002). 
 
There was a statistically significantly higher number of oral problems (candida, dental 
abscess and periodontitis) reported by the diabetic patients compared to non-diabetics. 
This difference may be due to the immune-suppression caused by diabetes.  
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Lamster et al (2008) indicated that the presence of candidiasis is a common manifestation 
of immuno-compromised state and these acute oral infections are frequent complications 
of marginally controlled or uncontrolled diabetes. 
 
Periodontal disease and tooth decay were reported as the most common oral cavity 
problems among diabetic and non-diabetic patients respectively. Periodontal disease is a 
recognized and well-documented complication of diabetes (Lamster, et al. 2008). In a 
review done by Taylor and Borgnakke (2008) two out of three studies where patients 
were not classified as Type 1 or 2 diabetes reported a greater prevalence, extent and 
severity of periodontal disease for at least one measure or index of periodontal disease. 
Mealey (2003) and Vernillo (2003) found that increased gingival crevicular fluid glucose 
levels were much higher in the diabetic patients, and this may diminish the ability of 
periodontal fibroblasts to contribute to periodontal healing. This may indicate that the 
prevalence of moderate to severe gingival inflammation was generally high among 
diabetic patients compared to non-diabetic patients. Ogunbodede et al (2005) found a 
higher average gingival index and a higher plaque index among diabetic patients 
compared to non-diabetic patients. 
 
In this thesis, problems with the teeth were either experienced “sometimes” or “often” 
more by the diabetic patients compared to just less than half of the non-diabetic patients. 
Pain in the mouth was the most reported problem among diabetics. These findings may 
be directly related to the fact that diabetic patients exhibited more caries, periodontal 
problems and oral pathology which are all associated with pain and discomfort. 
 
The most common teeth problems reported by diabetic patients and non-diabetic patients 
were caries and tooth ache respectively. The literature shows a lack of consistency 
regarding the relationship between diabetes and dental caries. Some investigators 
(Lamster et al. 2008; Mealey, 2003 and Zielinski et al. 2002) observed higher levels of 
dental caries among the diabetic patients. In some studies, the increased rates of dental 
caries were associated with xerostomia or increased gingival crevicular fluid glucose 
levels (Mealey, 2003).  
 
 
 
 
 88
In others, the increased rate of caries was attributed partially to decreased salivary flow 
and increased levels of carbohydrates in the parotid saliva (Murrah, 1985).  
 
The most commonly reported gum problem was bleeding, followed by painful gums. 
Because gingivitis is a reversible inflammatory condition, it is characterized by bleeding 
and this could be indicative of the fact that diabetic patients had more severe gingival 
inflammation. Tan et al (2006) found that diabetic patients had poorer oral hygiene as 
measured by plaque index, more severe gingival disease as measured by the gingival 
index and higher severity of periodontal disease based on probing depths and clinical 
attachment levels compared to non-diabetic patients. 
 
Most diabetic patients indicated that they experienced problems with sense of taste.  
Taste disturbances have been reported in patients with DM, although not by all 
researchers. Its occurrence is thought to be due to reduced salivary flow and changes in 
food intake associated with diabetic disease management (Lamster et al. 2008). 
 
Diet, exercise, weight control and medication are the mainstays of diabetic care (Mealey, 
2003). A higher proportion of diabetic patients followed a healthy eating plan compared 
to non-diabetic patients. This may be due to the health education instructions on healthy 
eating and exercising, as part of the overall management of diabetic patients in order to 
keep diabetes under control. During patient education, health workers often emphasize 
the need to exercise and eat healthily and results of the present study perhaps indicated 
how well the health workers have managed to educate diabetic patients in this area of 
disease management. Diabetic patients reported exercising because they wanted to be 
healthy and fit. Diabetic patients may be exercising more than non-diabetic patients in 
order to comply with proper management of their diabetes status as a recommendation 
from their physicians. 
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Nearly all the diabetic patients perceived their quality of life as “not satisfactory” due to 
the complications of diabetes compared to less than five per cent of non-diabetic patients. 
There is much morbidity and mortality is associated with diabetes and as such diabetes 
complications have important effects on the patients’ quality of life. Papadopoulos et al 
(2007) found that nearly all their study sample suffered from co-morbidity. In the present 
study, almost all of diabetic patients indicated that being diabetic had changed their life 
for the worse. Perhaps the fact that diabetes affects multiple organ systems had an impact 
on how diabetic patients perceived their life once they had been diagnosed with diabetes. 
 
Almost all the diabetic patients acknowledged that their life changed after being 
diagnosed with diabetes. The majority of diabetic patients started experiencing oral health 
problems after being diagnosed as a diabetic and reported having at least one diabetic 
complication. Three quarters of the diabetic patients were taking oral hypoglycemic drugs 
to control their condition. A higher proportion of diabetic patients were “not satisfied” 
with their quality of life, and this perception could be due to the medication, dietary 
restrictions and the actual symptoms of the disease, all of which lead to a deterioration in 
QOL (Papadopoulos et al. 2007). Logistic regression models indicated that diabetic 
patients were almost six times likely to perceive their life as “unsatisfactory” compared to 
non-diabetic after having adjusted for age and gender variables. This difference in 
perception was statistically significant. After adjusting for age, gender, healthy eating and 
exercising characteristics, diabetics were now almost ten times more likely to perceive 
themselves as “not satisfied” with their QOL. This indicates that not exercising has an 
influence on the perceived quality of life, even though healthy eating habits may be 
practiced. This perception was statistically significant although the confidence interval 
was wide. 
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6.2 Conclusions 
 
It can be concluded from the present study that diabetic patients had more oral health 
problems compared to non-diabetic patients. This study found that diabetic subjects do 
exhibit oral complications and should therefore be encouraged to consult dentists on a 
regular basis to ensure that their oral cavity is as healthy as possible. This will allow them 
to be compliant with the nutritional recommendations of a diabetic patient. The dental 
team could have a significant, positive effect on the oral and general health of patients 
with diabetes mellitus (Lamster et al. 2008). This may indicate the need for targeted 
intervention programs aimed at educating the diabetic patient on oral health problems. 
 
Intervention strategies for diabetics are needed to assist patients in maintaining normo-
glycaemia as this has an impact on the progression of diabetic complications and thus on 
the quality of life in general. Furthermore, aggressive management of periodontal disease 
in a patient with diabetes may diminish the inflammatory milieu’s detrimental effects on 
diabetes control and the cardiovascular health of the patient (Skamagas et al. 2008). 
 
There is a need for an increased collaboration between physicians and the entire dental 
team to enable more interaction in the management of diabetic patients and improve the 
outcomes for diabetics. The dentist can play a role by assisting the patient to maintain 
glycaemic control; by treating oral infections and by instructing the patient with diabetes 
to maintain rigorous oral hygiene and a proper diet (Vernillo, 2003). Furthermore, 
dentists can play a very crucial role in identifying individuals at risk or with poorly 
controlled diabetes because of associated conditions like periodontitis and candida which 
are consistent with diabetes-related conditioning of periodontal responses to plaque 
(Bjelland et al. 2002). The oral cavity may exhibit the first signs or symptoms of an 
undiagnosed or poorly controlled diabetic condition, so dentist and dental hygienists must 
be aware of these signs and symptoms and know what to do if they are present (Mealey, 
2008). Although not pathognomic for diabetes, conditions such as multiple periodontal 
abscesses, mobile teeth including bone loss, inflammation spreading through the attached 
gingiva etc may result from uncontrolled hyperglycaemia (Bjelland et al. 2002). 
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Detection of these conditions provides a means for early diagnosis of systemic disease 
like diabetes since the dentist has to refer suspicious cases to a physician for further 
investigations. 
 
There is a great need for oral health promotion strategies targeted at the community at 
large so that they can understand the intimate and bidirectional relationship that exists 
between diabetes and oral health, and be alert to any mouth problems. This would enable 
individuals to cope better should they develop diabetes and it would empower others to 
take better care of those family members who are diabetic. There’s a need for future 
studies among diabetic patients which will measure the mobility index, loss of 
attachment, CPITN index glyceamic control and compare how the findings relate to the 
Type of diabetes, medication taken and the period that a patient has been diabetic. 
 
6.3 Study limitations 
 
Variables related to smoking, stress and access to health care were not recorded. The oral 
examination did not include a mobility index, loss of attachment or periodontal index to 
measure pocket depths. However, a longitudinal study design would be best to elicit 
accurate information regarding the development and progression of oral diseases 
especially periodontal disease. There is a paucity of South African studies carried out on 
this topic and therefore most of the literature and statistics used were based on literature 
done from countries abroad. 
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Appendix I - Questionnaire 
 
DATA CAPTURE SHEET FOR DIABETIC PATIENTS 
1. Date of examination:……………………………………….. 
2. Patient’s name:…………………………………………….. 
3. File no:……………………………………………………… 
 
DEMOGRAPHIC INFORMATION 
 
4. Date of birth (YY/M/D):…………………………………… 
5. Gender: …………………………………………………….. 
6. Ethnic group:………………………………………………. 
7. Do you have diabetes?:…Y/N…………………………….. 
8. How long have you had diabetes? ……………………….. 
9. Type of medication taken ………………………………… 
 
SECTION A 
10. Intra-oral Examination: 
10.1. DMFT: 
Tooth 
number 
Status Tooth  
number
Status       
18  38  
17  37  
16  36  
15  35  
14  34  
13  33  
12  32  
11  31  
21  41  
22  42  
23  43  
24  44  
25  45  
26  46  
27  47  
28  48  
 
 
D M F DMFT 
Total 
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11. Plaque Index based on Debris Index (Greene and Vermillion, 1964) 
0 = none (no debris or stain) 
1 = <1/3 of the tooth surface has debris 
2 = >1/3 of the tooth surface but not more than 2/3 has debris 
3 = more than 2/3 tooth surface has debris 
9 = not recorded 
 
 
12. Appearance of marginal gingiva adapted from (Löe & Silness, 1963) with 
addition of criteria 3 
0 = normal gingiva 
1 =  mild marginal gingivitis, slight colour change & oedema 
2 =  moderate gingival inflammation, redness & glazing 
3 =  Severe inflammation, marked redness & oedema, with ulceration or spontaneous 
bleeding 
 
13. Oral Pathology 
 Lesion Yes No 
13.1 No abnormalities   
13.2 Candida   
13.3 Angular Cheilitis   
13.4 Dental Abscess   
13.5 Minor Aphthous Ulcers   
13.6 Major Aphthous Ulcers   
13.7 Other   
 
14. Problems with the oral cavity: 
 Type of problem Yes No 
14.1 Periodontitis   
14.2 Poor wound healing   
14.3 Xerostomia   
14.4 Burning Sensation   
14.5 Halitosis   
14.6 Tooth decay   
14.7 Other (Please specify)   
 
SECTION B 
15. Oral function: 
15.1 Do you have pain in the mouth? never sometimes often 
15.2 Do you have problems with your teeth? never sometimes often 
 If yes, please explain    
15.3 Do you have problems with your sense 
of taste? 
never sometimes often 
15.4 Do you have problems with your gums? never sometimes often 
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16. History of oral problems 
When did you notice you had these problems? 
Before I became diabetic After I became diabetic 
 
17. Lifestyle: 
17.1 Do you follow any exercise routine?  Yes No Sometimes ……………….. 
17.2 If yes, why do you exercise?........................................................................ 
17.3 Do you follow a healthy eating plan? Yes No …………………………… 
17.4 When did you start following a healthy eating plan?................................... 
17.5 How many times did you exercise last month?............................................ 
17.6 Is it important to exercise when diabetic?.................................................... 
17.7 Is it beneficial to eat healthily when diabetic?............................................. 
17.8 Has being diabetic changed your life in any way? Yes or No …………… 
17.9 If yes, how has your life changed since becoming diabetic?....................... 
 
18.1 Quality of life 
Since becoming diabetic my quality of life has: Please tick appropriate answer. 
improved  
deteriorated  
stayed the same  
  
 
18.2 How do you perceive your quality of life? Please tick appropriate answer. 
I am very satisfied with it  
I am somewhat satisfied with it  
I am really not satisfied with it  
 
18.3 What is the reason for the above answer?................................................. 
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IPHEPHA LOKUGCWALISA IMINININGWANE YALABO ABANOSHUKELA 
1. Usuku lokuhlolwa:……………………………….. 
2. Igama:…………………………………………….. 
3. Inombolo ye fayili:……………………………… 
 
IMINININGWANE YESIGULI 
4. Usuku lokuzalwa (YY/M/D):………………………… 
5. Ubulili: ……………………………………………….. 
6. Uhlanga:……………………………………………….. 
7. Ngabe unaso isifo sikashukela? Yebo/Cha:………… 
8. Usunesikhathi esingakanani unoshukela…………… 
9. Udla muthi muni?.................................... 
 
ISIGABA SIKA “A” 
10. Ukuhlolwa ngaphakathi komlomo: 
10.1. DMFT :( Amazinyo awabolile, awangasekho nawagcwalisiwe) 
Inombolo 
yezinyo 
Isimo sezinyo Inombolo
yezinyo 
Isimo sezinyo      
18  38  
17  37  
16  36  
15  35  
14  34  
13  33  
12  32  
11  31  
21  41  
22  42  
23  43  
24  44  
25  45  
26  46  
27  47  
28  48  
 
D M F Isamba 
seDMFT 
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11. I indeksi ye plakhi 
0=ayikho 
1=<1/3 
2=>1/3 
3= ingxenye enkulu yezinyo imbozwe iplakhi 
9=ayibhaliwe 
 
 
 
12. Isimo sezinsini  isuselwe ku (Loe & Silness, 1963) kwase kongezwe inamba 
yesithathu 
 0 = izinsini azinalutho 
 1 = kune gingivitis encane, um’bala uhlukile kancane & zivuvukele 
 2 = kune gingivitis ebonakaloyo, umbala obomvana& nokukhazimula 
 3 = Kunebhande elibomvu elibonakala ngokugcwele kwi gingiva lusuka kwi  
  phaphila liye kwenye 
 4 = Kuvuvukele kabi, umbala ubomvu kakhulu & kuvuvukele, kwaze  
 ezilonda kanye nokopha okuzenzekelayo 
 
13. Izifo zomlomo 
 Isifo Yebo Cha 
13.1 Akukho zifo   
13.2 Inkwethu   
13.3 Amapapisi   
13.4 Ithumba lezinyo   
13.5 Isilonda esincane   
13.6 Isilonda esikhulu   
13.7 Okunye   
 
14. Izinkinga ngomlomo wakho: 
 Uhlobo lwenkinga Yebo Cha 
14.1 I periodontitis   
14.2 Izilonda azisheshi ukuphola   
14.3 Umlomo owomile   
14.4 Ukushoshozela   
14.5 Ukunukelwa kabi umlomo   
14.6 Ukubola kwamazinyo   
14.7 Okunye (Sicela ukuchaze)   
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ISIGABA SIKA “B” 
15. Ukusebenza komlomo: 
15.1 Unabo ubuhlungu emlonyeni? Cha,angikaze Ngezinye 
izikhathi 
kujwayelekile
15.2 Unazo izinkinga ngamazinyo akho? Cha,angikaze Ngezinye 
izikhathi 
kujwayelekile
 Uma ikhona chaza kabanzi 
 
   
15.3 Unayo inkinga ngokunambitha 
kwakho? 
Cha,angikaze Ngezinye 
izikhathi 
kujwayelekile
 Uma ikhona chaza kabanzi 
 
   
15.4 Unayo inkinga ngezinsini zakho? Cha,angikaze Ngezinye 
izikhathi 
kujwayelekile
 
16. Umlando wezinkinga zasemlonyeni 
Ngabe waqala nini ukubona ukuthi unezinkinga zomlomo? 
Ngaphambi kokuba noShukela Ngemuva kokuba noShukela 
 
17. Isitayela ophila ngaso 
17.1 Ngabe uyawuvocavoca umzimba?   Yebo     Cha                Ngesinye isikhathi 
17.2 Uma ukwenza ukwenzelani ukuvocavoca mzimba?................................................ 
17.3 Emasontweni amabili adlulile uye kangaki ejimini?................................................ 
17.4 Ngabe indela odla ngayo inempilo noma umsoco?.................................................. 
17.5 Kulenyanga edlule uzikhiphe kangaki ukuyodla?.................................................... 
17.6 Ngabe kubalulekile yini ukujima uma unoShukela?................................................. 
17.7 Ngabe kunayo  yini inzuzo ukudla okunomsoco uma unoShukela? Yebo   Cha...... 
17.8 Ngabe ukuba noShukela kuyishintshile impilo yakho? Yebo   Cha    ..................... 
17.9 Ishintshe kanjani impilo yakho njengoba unoShukela?............................................ 
 
18. Izinga lempilo 
18.1 Emveni kokuba noShukela izinga lempilo yami li: Sicela umake impendulo efanele. 
Likhuphukile  
Lehlile  
Lisafana, akushintshanga lutho  
 
18.2 Ulibona linjani izinga lempilo yakho? Sicela umake impendulo efanele 
Linganelisa kakhulu  
Nganelisekile nje  
Anganelisekile neze  
 
18.3 Ngabe yisiphi isizathu sempedulo engenhla?................................................ 
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Appendix II-Informed Consent Form 
 
UNIVERSITY OF THE WESTERN CAPE 
 
FACULTY OF DENTISTRY 
 
INFORMED CONSENT FOR ORAL EXAMINATION 
 
Dear ................................……............................... 
 
I am Dr NM Radebe, a Masters student from the Department of Community Oral Health at the 
University of the Western Cape. Diabetes mellitus is described as one of the most common 
diseases in medicine and it is a growing public health problem. It is as a chronic disorder of the 
carbohydrate, fat and protein metabolism. It is characterized by a very distinct feature - the 
elevation in blood glucose levels. This may occur as a result of a defect in insulin secretion from 
the pancreas, a change in insulin action or both. An elevation in blood glucose levels is also 
known as hyperglycemia and tends to affect almost all body tissues including those of the mouth. 
We are interested in interviewing you on regarding any habits that you may have to see if there 
are ways in which we can prevent any mouth problems from developing or help with any mouth 
problems you may have. 
 
The interview will take about 10-15 minutes. There are no risks in participating. All information 
gathered in the study will be treated as strictly confidential. No one will have access to this 
information except the researcher. Neither your name nor anything that identifies you will be used 
in any reports of this study. All information collected will be maintained and stored in such a way 
so as to keep it as confidential as possible. Your participation is voluntary and you may withdraw 
from the study at anytime without any penalties. If you would like to take part in the study, please 
sign the bottom of this letter. If you would like to know anything more about the study, please 
contact Dr N Radebe on telephone number at work 031-2624471 or at home on 031-2692891. 
 
Thank you for your co-operation. 
Yours sincerely 
 
Dr NM Radebe 
----------------------------------------------------------------------------------------------------------- 
I understand what will be required of me to take part in the study. I agree to participate in 
the research being undertaken by Ms N Radebe. I understand that at any time I may 
withdraw from this study without giving a reason and without affecting my treatment in the 
future. 
 
Name:………………………………….          …………………………….. 
(print in block letters)                                             (Signature) 
 
(Witness)    Date: ……………………………… 
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Appendix III- Tables of the Results presented in the Figures 
 
Comparison of the appearance of marginal gingival between diabetic and non-
diabetic patients 
 
Figure 2 Diabetic (n=150) Non-diabetic(n=150) 
 freq % Freq % 
Normal 2 2.0 45 30 
Mild 32 21.33 59 39.33 
Moderate 81 54 35 23.33 
Distinct Red 
Band 29 19.33 10 6.67 
Severe 5 3.33 1 0.67 
Total 150 100.0 150 100.0 
 
 
Comparison of the appearance of oral pathology lesions between diabetic and non-
diabetic patients 
Figure 3  Diabetic (n=150) Non-diabetic (n=150) 
 Freq % freq % 
Candida 62 41.3 12 8.0 
Angular chelitis 9 6.0 1 0.7 
Dental abscess 24 16.0 4 2.7 
Ulcer 21 14.0 3 2.0 
Other 1 0.7 0 0.0 
None 65 43.3 131 87.3 
Total 182  151  
 
 
Comparison of the appearance of oral cav 
ity problems between diabetic and non-diabetic patients 
Figure 4 Diabetic (n=150) Non-diabetic (n=150) 
 Freq % freq % 
Perio 79 52.7 22 14.7 
Wound 19 12.7 4 2.7 
Xerostomia 79 52.7 11 7.3 
Burning Sensation 14 9.3 2 1.3 
Halitosis 56 37.3 18 12.0 
Tooth decay 74 49.3 87 58.0 
No problem 7 4.7 46 30.7 
Total 328  190  
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Comparison of the appearance of the type of teeth problems between diabetic and 
non-diabetic patients 
 
Figure 5 Diabetic (n=150) Non-diabetic (n=150) 
 Freq % freq % 
Caries 51 34.0 42 28.0 
Mobile 17 11.3 3 2.0 
Toothache 32 21.3 35 23.3 
Sensitivity 18 12.0 14 9.3 
Not applicable 59 39.3 80 53.3 
Total 177  174  
 
Comparison of the appearance of gum problems between diabetic and non-diabetic 
patients 
 
Figure 6 Diabetic (n=150) Non-diabetic (n=150) 
 Freq % freq % 
Bleeding 58 38.7 33 22.0 
Swollen 13 8.7 3 2.0 
Painful 10 6.7 8 5.3 
Spontaneous bleeding 9 6.0 2 1.3 
Not applicable 71 47.3 112 74.7 
Total 161  158  
 
Length of time diagnosed with diabetes 
 
Figure 7 Diabetic (n=150) 
 Freq % 
1 to 2 years 19 12.67 
3 to 5 years 33 22.0 
6 to 10 years 28 18.67 
More than 10 years 70 46.67 
 
 
Type of diabetes medication taken by the diabetic participants 
Figure 8 Diabetic (n=150) 
 Freq % 
Insulin 12 8 
Oral hypoglycemic 112 74.67 
Combination 26 17.33 
 
 
 
 
 
